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Abstract 
Evaluation of insertion-deletion polymorphisms with the kit Qiagen 
Investigator
®
 DIPplex for forensic application in South Africa 
G. Jacobs 
MSc Thesis, Department of Biotechnology, University of the Western Cape 
 
Insertion-deletion polymorphisms (indels) have been underutilized in forensic 
identification of individuals in comparison with single nucleotide polymorphisms 
(SNPs) and short tandem repeat (STRs) systems. The use of indels for the purpose 
of human identification is more advantageous than previously used methods as it 
combines desirable characteristics of both the SNPs and STRs i.e. low costs and 
simplistic typing methods as well as indels having small amplicons size, making 
them suitable for genotyping highly degraded DNA. Currently there is only one 
commercial kit available for the forensic community, the Investigator
® 
DIPlex kit 
(Qiagen), which cover a total of 30 indel loci distributed over 19 autosomal 
chromosomes. 
The objective of this study was to evaluate the Qiagen Investigator® DIPplex kit 
for forensic application in South Africa. The kit‘s performance was evaluated by 
comparing different extraction methods; sensitivity, robustness and 
reproducibility were evaluated and forensic parameters (match probability, power 
of discrimination, polymorphism information content, power of exclusion and 
typical paternity index) were estimated based on population data generated from 
five South African populations (Afrikaner, Mixed Ancestry, Indian-Asian, Xhosa 
and Zulu). Population comparisons were performed using FST-analysis, factorial 
component analysis as well as phylogenetic tree construction. 
DNA was extracted from buccal swabs and whole blood collected from a total of 
512 individuals from the five South African population groups and genotyped 
using the Qiagen Investigator® DIPplex kit. Sanger DNA sequencing and 
sequence alignments confirmed the presence of a null allele at locus HLD97 
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which was present in high frequency in the Xhosa and Zulu populations. This 
observation was made in 14 individuals belonging to the Xhosa and Zulu 
populations. Null allele frequencies in all five South African populations were 
also estimated. Null alleles were estimated for all loci using analytical methods 
i.e. Charkraborty null allele estimator, Brookfield null allele estimators 1 and 2 
and ML-NullFreq software program.  
The kit performed well in the laboratory, not requiring any additional reagents or 
instrumentation and successfully generating profiles with input DNA amounts as 
low as 0.2 ng/µL.  
Although well suited for forensic application, the Qiagen Investigator® DIPplex 
kit showed some drawbacks with regards to application on South African 
populations. The presence of a null allele at the HLD97 locus as well as indication 
of population substructure affects allele frequency estimates for the South African 
populations. Correction for population substructure as present within the South 
African populations should be considered using FST analysis and it is 
recommended that the HLD97 locus should be excluded from any kinship 
analysis performed on South African populations. 
Date 1/12/2014 
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Chapter One 
Literature review 
 
General Introduction 
Forensic genetics has evolved into a ground breaking field with developments and 
advances that has placed it on the forefront of innovative and cutting edge 
research. With an ever increasing dependency on forensics in crime solving, there 
is a need for faster sample processing and higher output of results that meet high 
quality standards. In its quest to fulfil these requirements, the field of forensics 
has made ground breaking progress and breakthroughs. 
 
1.1. A brief history of forensic genetics 
Figure 1.1 summarises some of the developments and advances in forensics. The 
first steps in human identification were taken with the application of human blood 
groups and protein electrophoresis as methods of distinguishing between 
individuals (Reviewed in Jobling and Gill, 2004). The ABO, MN and Rh systems 
were the most common systems used in the 1900s. All three systems were based 
on distinguishing between individuals on the bases of the different phenotypes 
that exists for the blood groups. The protein electrophoresis method was based on 
the existence of protein polymorphisms and isoenzymes for red blood cells and 
blood serum. These applications had their own shortcomings. Human blood 
groups and protein techniques could only be applied to these types of samples. 
Although these early methods hinted at the forensic possibilities, they were 
limited by rapid DNA degradation due to bacterial and environmental exposure 
and the inability to distinguish DNA mixtures. 
The first DNA typing method was described by Dr Alec Jeffreys in 1984 (Jeffreys 
et al, 1985; Gill et al, 1985). DNA Fingerprinting was the first genetic method 
applied in crime solving.  
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Figure 1.1 A timeline for the developments that have shaped forensics (Jobling and Gill, 2004) 
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The technique is based on the differences in length of repeat DNA sequences 
known as variable number tandem repeats (VNTRs). The VNTRs allow for 
human identification as the number of repeat sequences varies between 
individuals, variation that is due to genetic inheritance and recombination which 
results in a unique DNA fingerprint profile. Figure 1.2 illustrates the steps used to 
create a DNA fingerprint profile method known as restriction fragment length 
polymorphism (RFLP). This technique allowed for comparison between crime 
exhibits and reference DNA samples. Although the technique had its drawbacks 
like being labour intensive, it laid the foundation for forensic science. 
 
Figure 1.2 The DNA fingerprinting process (Image from www.buzzle.com). 
Application of the revolutionary technique that is today used on all biological 
platforms, the polymerase chain reaction (PCR) has allowed a way to overcome 
the requirement of high DNA concentration by earlier methods (Saiki et al, 1985; 
Mullis and Faloona, 1987). Simply put, PCR allows amplification of DNA 
segments by denaturing a DNA strand and using the denatured single DNA strand 
as a template for making more DNA copies. 
The idea of PCR developed with individual scientific discoveries that eventually 
lead to the PCR process that is known today. First and foremost the idea of PCR 
started with the discovery of the DNA double helix structure by James D. Watson 
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and Francis Crick and their postulation that DNA can be replicated (Watson and 
Crick, 1953). This was followed by the discovery of, among others, the first DNA 
polymerase by Arthur Kornberg by 1957 (Lehman et al, 1958) and the first taq 
enzyme Thermus aquaticus by Thomas D. Brock in 1969 (Brock, 1969). Kary 
Mullins is an American biochemist who worked on the process of PCR in the 
1980s. He successfully demonstrated the PCR process in 1985 (Saiki et al, 1985). 
His improvements on PCR which were based on the use of taq polymerase which 
is heat resistant unlike DNA polymerase, revolutionised PCR and its application 
in science. For his work on PCR, Kary Mullins was awarded the Nobel Prize for 
Chemistry in 1993. 
PCR is more sensitive, allowing amplification of minute amounts of DNA. It has 
also allowed the use of microsatellites and other genetic markers than being 
limited to using VNTRs. It has also allowed for simultaneous amplification  
 
of more than one target sequence in one PCR reaction in a process called a 
multiplex PCR reaction. 
 
1.2.Multiplex PCR reactions 
Multiplexing has allowed amplification of multiple loci at the same time, an 
advantage in forensic application. (Chamberlain et al, 1988). It is cost efficient 
and less labour intensive than performing individual PCR reactions as there is a 
decrease in the PCR reagents used and preparation time is cut short. 
 
Since a multiplex PCR reaction is essentially multiple PCR reactions taking place 
at once, the success of the reaction lies in getting all the different components 
from each reaction to work together to produce successful amplification of all loci 
that make up the multiplex. Some of key factors to consider include: 
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1.2.1. PCR primers- (length, GC content): 
The length (18-24 bp) and Guanine and Cytocine (GC) content (35 – 60 %) are 
the two principle factors to keep in mind when designing primers (Reviewed in 
Edwards and Gibbs, 1994; Innis et al, 2012). The length and GC content has an 
influence on the formation of primer artefacts (primer dimers and hairpin 
formations) which has a direct impact on the PCR yield. Primer concentration also 
contributes to the formation of primer artefacts and should be considered as well. 
 
1.2.2. Annealing temperature and cycling conditions: 
The annealing temperature for a multiplex reaction is determined by the primer 
length and GC content. Therefore, the primers should be designed to have 
annealing temperatures in the same range (56 – 60 oC) although lowering the 
annealing temperature by 4 – 6 oC for co-amplification of multiple target areas has 
proven successful (Markoulatos et al, 2002). Extension times also need to be 
considered to allow complete amplification of all loci. 
 
1.2.3. Competing components 
Interaction of the other components in PCR amplification is also very important. 
With multiple reactions taking place simultaneously, the polymerase enzyme, 
buffers and dNTPs amounts should be balanced to allow sufficient reagent 
amounts for each individual loci being amplified (Reviewed in Edwards and 
Gibbs, 1994). 
The discrimination power of a forensic marker is vital. As important as it is to 
include an individual as a donor of DNA it is just as important to be able to 
exclude an individual as a DNA donor. The application of PCR multiplexing 
forensic analysis has allowed an increase of loci to be amplified simultaneously as 
discrimination power increases with an increase of the number of loci included in 
a panel of forensic markers. 
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Multiplex PCR reactions are a key element to any forensic lab and have 
eliminated tedious laboratory work by allowing streamlining of amplifications and 
allowing for high throughput of sample processing. 
 
1.3. DNA sources 
With the advances in forensic technology, it broadened the type of samples to be 
analysed. PCR allowed analysis of samples on nuclear level and therefore any 
DNA sample could be analysed including blood, hair and tissue, allowing for 
potentially any type of body fluid evidence collected at crime scenes to be 
analysed for forensic purposes (Table 1.1). 
Table 1.1 Common types of DNA samples collected for forensics analyses. 
Type of crime Exhibit DNA Source 
Sexual assault Intimate swabs from genital 
areas, Oral swabs, 
Underwear, Condoms 
Semen 
Saliva 
Epithelial cells, hair 
Murder 
 
Bloody clothing 
Murder weapons 
Human remains 
Blood 
Epithelial cells, Saliva 
Bones, Human tissue, 
hair 
Burglary Food items, cigarettes, 
clothing items, weapons 
Blood, Saliva, Epithelial 
cells 
 
1.4. Forensic markers 
The choice of forensic markers plays a key role, and depends on the type of 
forensic samples being processed and the different forensic analysis being 
performed. To be a useful forensic marker, the following qualities serve as a few 
key requirements: 
i) high discrimination power 
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ii) amplification from low template concentration 
iii) good multiplexing ability 
iv) no complicated and expensive instrumentation or chemistries required 
v) distribution throughout the genome 
The different types of forensic markers have evolved from the protein genetic 
markers and the first single nucleotide polymorphism (SNP) markers in the 
human leukocyte antigen (HLA) locus (reviewed in Budowle and Van Daal, 
2008). The protein markers, although polymorphic, lacked discrimination power 
and did not allow analysis of all body fluids or tissue. The human leukocyte 
antigen locus provided sensitivity but lacked in discrimination power and did not 
perform well with DNA mixtures. 
The forensic markers currently used are at the genetic level, allowing any body 
fluid type that contains nucleated cells to be forensically analysed, overcoming the 
limitations of the initial human identification systems used, which only allowed 
specific types of body fluids to be analysed (reviewed in Budowle and Van Daal, 
2008). The high concentration requirement was overcome with the use of PCR 
which allowed amplification of small amounts of DNA. 
 
1.4.1. Current forensic DNA markers 
1.4.1.1. Short Tandem Repeats (STRs) 
STRs are the most popular choice of forensic marker (Edwards et al, 1991; 
reviewed in Guichoux et al, 2011). They are widespread throughout the human 
genome and contain repeat units of two to seven base pairs in length. STRs differ 
in the length and the number of repeat units. Autosomal STRs are the most 
commonly used type of STR used in forensics and are present on autosomal 
chromosomes. A huge factor for autosomal STRs as choice forensic marker is due 
to them meeting the requirements of a useful forensic marker including being 
highly polymorphic. Autosomal STRs are also used in kinship analysis. Their 
application in kinship analysis is common but is not without shortcomings. These 
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include the presence of mutations and null alleles which can lead to false 
exclusions (Chakraborty and Zhong, 1994; Brinkmann et al, 1998). Despite their 
usefulness, STRs have limitations when dealing with forensic samples of a 
degraded nature. To increase the success rate of DNA typing of degraded DNA, a 
different approach has been applied. MiniSTRs can successfully be used to 
amplify highly degraded DNA. The principle is based on decreasing the PCR 
product size being amplified by moving the primers closer to the STR region 
(Wiegland and Kleiber, 2001; Butler et al, 2003). The advantages of the technique 
rests on the fact that these minSTRs are still compatible with loci being used for 
database purposes while producing better results than the conventional STRs.  
 
Y-STRs are another type of forensic marker that has become useful in forensics 
(Butler, 2003). Y-STRs are present on the male Y chromosome, specifically on 
the non-recombining portion of the Y chromosome (NRY). The NRY is useful in 
tracing paternal lineage as it is passed on from father to son, unchanged, with 
variation only arising from a mutational event (Reviewed in Jobling et al, 1997). 
This important feature is useful in paternity testing, paternal lineage studies as 
well as sexual assault cases where DNA mixtures are common and it is difficult to 
differentiate between multiple male donors. To date, Y-STRs have been 
extensively researched and resulted in a high amount of Y-STR loci, with over 
400 Y-STRs having been characterized and 186 Y-STRs having been investigated 
(Jobling et al, 1997; Ballantyne et al, 2010). 
 
Mutations play an important role in the use of forensic markers in forensics. 
Mutational events are measured by comparison of the genotype between parent 
and offspring. STRs also have low mutation rates with an average mutation rate of 
10
-3
 (Reviewed in Goldstein and Pollock, 1997). Mutation rates vary between loci 
with certain loci having a higher mutation rate than others. The mutation rates of 
the thirteen core STR loci as used by the Federal Bureau of Investigation (FBI) for 
their Combined DNA Index System (CODIS) system have been researched and 
are available at (http://www.cstl.nist.gov/biotech/strbase/mutation.htm). 
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In kinship analysis, mutations have a direct impact on result interpretation as 
mutations could be the difference between exclusion and an inclusion. Paternity 
determination is based on the principle that a paternal parent will pass on the same 
Y-chromosome to his son based on the lack of recombination of the NRY portion. 
A mutation at the Y-STR loci will result in a different Y-STR haplotype being 
observed and consequently, exclusion. But the lack of recombination places a 
limitation on the use of Y-STRs when it comes to individual identification which 
is ideally required for forensic purposes. As the NRY portion is passed on through 
paternal lineage, the implication is that no one male individual can be identified as 
the donor of DNA as any of the male family members (brother, uncle etc.) will be 
in possession of that Y-STR haplotype.  
Recent studies have uncovered the presence of rapidly mutating Y-STRs (RM Y-
STRs) (Ballantyne et al, 2010; Ballantyne et al, 2012). These Y-STR loci have a 
higher mutation rate than other Y-STRs that have an average mutation rate of  
2.8 X 10
-3
 (Kayser et al, 2000; Kayser and Sajantila, 2001). During a study by 
Ballantyne et al (2010) a mutation rate above 1 x 10
-2
 was noted for the RM-STRs 
investigated. The discovery of RM Y-STRs presents the possibility of their use in 
differentiating between individual male family members. Due to the high 
mutation rates of these Y-STRs, unique Y-STR haplotypes are assigned to male 
individuals that are consequently not identical to the haplotypes of their male 
family members. Future applications in population studies are also possible, 
especially in populations that have undergone certain changes like population 
substructure or cultural effects, resulting in limited Y-chromosome diversity. 
 
1.4.1.2. Single Nucleotide Polymorphisms (SNPs) 
Among human polymorphisms, single nucleotide polymorphisms are the most 
abundant class. SNPs have characteristics that make them favourable for forensic 
application: they have a low mutation rate (10
-8
) and they can be amplified in 
short amplicons, they are ideal for high throughput processing and can be 
analysed using the current automated instrumentation (reviewed in Amorim and 
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Pereira, 2005). This is ideal when considering the needs in forensic analysis i.e. 
high throughput and low costs. 
There are different DNA typing methodologies that can be applied, with the SNPs 
typing method chosen being determined by the outcome required. Applications of 
SNPs include ancestry informative markers (AIMs), identity testing for 
individualization and lineage SNPs located on the mitochondrial DNA genome 
and Y chromosome (Reviewed in Budowle and Van Daal, 2008). Each typing 
method also has its own requirements for the type of SNPs chosen. For example, 
the SNPs used for identity testing has to have high heterozygosity and low 
population heterogeneity whereas SNPs used as AIMs would require low 
heterozygosity and high population heterogeneity. 
There has been an attempt to create a SNP multiplex assay for the purpose of 
human identification. The assay was created by the consortium group SNPforID 
group and consists of 52 unlinked autosomal SNPs which are highly polymorphic 
within the European, Asian and African populations (Sanchez et al, 2006). The 
aim of the project was to create a multiplex SNP assay which consisted of all the 
qualities needed to be used for forensic typing, which includes multiplexing and 
the use of high throughput DNA typing platforms. The project successfully 
identified 52 polymorphic SNPs and used standard instrumentations and methods 
available in forensic laboratories, further allowing the possibility of applying the 
52 SNPs for other genotyping methods. 
Due to the biallelic nature of SNPs, SNP application requires a higher number of 
SNPs loci to equal the discrimination power of the current STR kits in use 
(Sobrino et al, 2005; Reviewed in Budowle and Van Daal, 2008). Furthermore, 
the characteristics of the population of interest should be considered including 
allele frequencies and genomic location as these have an influence the 
discrimination power (Zhong et al, 1999). A minimum of 50 SNPs are needed to 
equal the discrimination power of 10 to 15 STRs (Gill, 2001; reviewed in Amorim 
and Pereira, 2005). The role of mutations and null alleles in SNPs, as with all 
forensic markers, and their influence in population genetics needs to be 
considered as well. Furthermore, the biallelic nature of SNPs makes interpretation 
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of mixture profiles difficult. The advantages of SNPs might also be considered as 
disadvantages, depending on the needs and outcomes required by the user. For 
forensic requirements, SNPs are difficult to streamline and might be a better 
alternative as a supplementary test in conjunction with other established DNA 
typing methods. Another drawback of SNP application is the time taken to 
analyse SNP results, as analysis of data for a SNP panel in excess of fifty SNPs is 
time consuming. However, where STR markers fail in analysis of degraded DNA, 
SNPs can be a welcome alternative in generating successful results. 
 
1.4.1.3. Insertion-deletion polymorphisms (Indels) 
Indels are known as length polymorphisms with the insertion or deletion of 
nucleotides in the genome (Weber et al, 2002). Insertion-deletion polymorphisms 
are a result of a mutational event that occur possibly only once in the human 
evolutionary past (Pereira and Gusmao, 2012). As a result of the mutational event, 
indels can have an ancestral and mutational state (two allelic states) and are 
therefore known as biallelic polymorphisms (Pereira and Gusmao, 2012). What 
have sparked interest in indels are the qualities they possess; combining the 
properties of SNPs and STRs that have made these polymorphisms favourable 
choices as forensic markers for forensics: 
i) Indels are distributed throughout the genome, just like SNPs and STRs. 
Indels make up about 20 % of human polymorphisms (Weber et al, 
2002). 
ii) They possess low mutation rates. This is especially applicable to 
relationship testing and identification purposes. 
iii) Due to the nature of forensic samples, the system chosen to analyse 
forensic samples need to be able to handle samples of a degraded 
nature. Indels can be amplified in short amplicons. This quality allows 
for PCR amplification of degraded DNA as well as being an advantage 
for multiplexing purposes. 
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iv) Genotyping can be performed using current genotyping methods (PCR 
and capillary electrophoresis) and does not require expensive 
chemistries or instrumentation. Therefore they are cost efficient and 
provide uncomplicated and speedy analysis. 
 
1.5. Commercial kits 
In forensics, multiplex PCR reactions have successfully been used for 
amplification of STR loci. Due to the time and costs involved in designing and 
optimising PCR multiplex reactions, most forensic laboratories make use of 
commercially manufactured multiplex kits. These kits contain all the components 
for successful PCR amplification with initial optimisation of reagent 
concentrations performed. The first multiplex system consisted of four STR 
markers (THO1, FES/FPS, vWA and F13A1) and was developed by the Forensics 
Science Services in the United Kingdom (Clayton et al, 1998). Multiplex system 
development has advanced to an increase in the number of loci as well as the 
inclusion of a gender marker (Amelogenin). As previously mentioned, an 
important advantage to the increase of the number of loci used is the increase in 
discrimination power. The commercial kits make use of established and known 
loci that have been extensively researched. Thirteen core STR loci (CSF1PO, 
FGA, THO1, TPOX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, 
D16S539, D18S51 and D21S11) were established for inclusion within CODIS 
(Budowle et al, 1998). These core thirteen loci as well as other autosomal STR 
loci have been incorporated by companies within and outside the United States for 
use in their STR multiplex kits. The amount of loci have also increased with as 
many as 24 STR loci now being amplified within PCR multiplex kits, as in the 
case of the GlobalFiler® Express PCR multiplex kit (Life Technologies) and 
PowerPlex® Fusion System (Promega). Y-STR multiplex systems also consist of 
increased Y-STR loci amounts such as 23 loci in PowerPlex® Y23 System 
(Promega) and 27 loci in Yfiler® Plus PCR Amplification Kit (Life 
Technologies). 
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The kits undergo stringent optimisation and validation by the manufacturer, 
essentially removing the time, cost and labour involved in developing and 
optimising an in-house PCR multiplex system. These developments have provided 
standardization of protocols between laboratories, with comparative DNA results 
being produced as laboratories are using similar protocols and forensic markers 
globally. Companies that commercially provide kits for autosomal STRs, Y-STRs 
and indels include Life Technologies, Promega Corporation, Qiagen and Biotype, 
to name a few. Over fifty kits are commercially available for autosomal STRs 
alone. These commercial kits need to meet strict quality requirements including 
the validation studies mentioned previously. 
 
1.5.1. Qiagen
®
 Investigator DIPplex kit 
The Qiagen® Investigator DIPplex kit is the first commercial indel kit. It allows 
for multiplex PCR amplification of 30 indel loci including Amelogenin for gender 
determination. The 30 indel loci are located across 19 autosomal chromosomes. 
Twenty eight loci are located in intronic coding regions and two loci (HLD133 
and HLD128) are located in intergenic regions (Rajeevan et al, 2003). The 30 loci 
are detected using fluorescence-labelled primers using 6-FAM™, BTG, BTY and 
BTR. The advantages of the kit include the absence of stutter peaks which further 
assists with DNA mixture interpretation and an increase of discrimination power 
when applied in addition to standard markers (Qiagen, 2011). 
The Qiagen® Investigator DIPplex kit has been evaluated in other countries. 
Population data for European countries including Finland, Germany, Denmark 
and North Portugal have been generated using the kit (Friis et al, 2012; Qiagen; 
Neuvonen et al, 2012; Carvalho and Pinheiro, 2013), as well as Asian countries 
namely Chinese and Korean populations (Li et al, 2011; Liang et al, 2013; Kim et 
al, 2014). African American populations were also evaluated (Fondevila et al, 
2012; LaRue et al, 2012). 
In certain populations namely the Spanish (Martin et al¸ 2012), African American 
(Fondevila et al, 2012, LaRue et al, 2012), Danes (Friss et al , 2012) and Iranian 
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populations (Poulsen et al, 2015), the presence of a null allele was detected at the 
HLD97 locus. A lack of population data for African populations is evident with 
only two studies (Fondevila et al, 2012, LaRue et al, 2012) reporting on African 
populations which makes the evaluation of the kit on South African populations 
valid. 
1.6. Quality control and standardization 
A very important and vital part of any laboratory is ensuring that quality standards 
and procedures are met and adhered to. In the field of forensics, this is even more 
so, as results obtained in forensic laboratories are used in criminal cases as crucial 
evidence. Furthermore, standardization of techniques are important for results to 
be replicated and compared for inter laboratory comparisons. An international 
forensic community exist consisting of organizations that determine standards and 
guidelines that aim to provide additional guidance to the bigger DNA community 
worldwide including Scientific Working Group on DNA Analysis Methods 
(SWGDAM) (www.swgdam.org), International Society for Forensic Genetics 
(ISFG) (www.isfg.org) and European DNA Profiling Group (EDNAP) 
(www.isfg.org/EDNAP), among others. Guidelines as recommended by 
SWGDAM can be accessed on the SWGDAM website 
(http://swgdam.org/docs.html). 
Some of the main issues that are looked at include the following: 
1.6.1. Laboratory staff competency 
Personnel performing analysis need to be suitably qualified, trained and 
competent. This is a process that needs to be monitored regularly. One such 
measure is performing regular proficiency tests. Proficiency tests evaluate not 
only the analyst‘s ability but also the laboratory‘s ability to obtain consistent 
results (Butler, 2005). 
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1.6.2. Instrumentation and chemistries 
Instruments have to serviced and maintained regularly. Instruments need to 
perform at their best with no possibility of incorrect results being reported due to 
technical errors. Servicing and maintenance is normally performed by the 
manufacturers of the instruments. These companies issue servicing and calibration 
certificates as proof of the maintenance performed which is often requested by the 
courts. The chemistries used in forensic science need to be evaluated and 
validated. Validation studies are carried out to ensure that the procedures and 
technologies laboratories implement are done so accurately and results obtained 
reflect these procedures. Developmental and internal validation studies should be 
carried out: 
 
1.6.2.1. Developmental validation 
These tests are performed, usually by the manufacturers of the kits, to test the 
chemistries and technologies used in the kits including the primer sets and the 
chosen marker sets. It includes a very extensive list of tests, testing for different 
variables including consistency, to test if a technique produces the same result 
each time it is performed, whether by the same or different laboratories. 
Environmental stress is another variable that is tested, again to determine if the 
same result is obtained repeatedly. Environmental factors play an important role 
in forensics as exhibits are often exposed to extreme weather conditions which 
influence the DNA quality. Validation tests include population studies, 
environmental studies and reproducibility studies. 
1.6.2.2. Internal validation 
These validation tests are performed by testing laboratories to test the 
experimental procedures and protocols established during validation, to see if the 
same processes can be successfully applied in one‘s own laboratory. 
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1.6.2.3. Laboratory competency 
Besides the individual sections or components that the laboratory consists of, 
laboratories as a whole are also evaluated to assess how these individual 
components perform together. This is monitored through laboratory audits that 
evaluate the laboratory operation in its entirety (Butler, 2005). Laboratories can 
also go through the process of being accredited. The assessment is performed by 
an accreditation body which stringently inspects every aspect of the laboratory 
and its performance relating to good lab practices (Butler, 2005).  
The process of accreditation is a method of determining the competency of 
laboratories to perform specific types of testing, measurement and calibration. 
Through accreditation, customers are provided assurance of reliability and 
competency in the services provided by laboratories. For laboratories, 
accreditation provides a means to determine workmanship quality and accuracy. 
Assessments are regularly performed to determine whether standards are 
maintained and to pinpoint possible areas for improvement. The process of 
accreditation is recognised nationally and internationally as a measure of 
competency. 
Different accreditation bodies exist worldwide. The accreditation body recognised 
in South Africa is the South African National Accreditation System (SANAS) 
(http://www.home.sanas.co.za/). 
Depending on the types of testing, measurement and calibrations performed by a 
laboratory, different standards can be implemented. For many of the accreditation 
bodies, ISO 17025 is now being used as the basis for accreditation for calibration 
and testing bodies and it is also the standard used by forensic science laboratories. 
This further supports inter-laboratory collaboration and result comparison. 
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1.7. Technological advances 
1.7.1. Instrumentation 
The forensic community has made huge strides in cutting down on labour and 
increasing sample processing in terms of speed and efficiency by improving the 
instrumentation used for forensic applications. It has moved from the forensic 
analyst doing most of the labour involved in analysis to semi automation, 
rendering the forensic analyst a mere operator of the instrumentation. Companies 
have seen the potential of instrumentation and have started focusing on 
manufacturing instruments to be used for routine analysis. Among the companies 
on the forefront of instrumentation development are Merck, Promega, Life 
Technologies and Bio-Rad. These companies have released instruments for 
performing PCR amplification, quantification, gel electrophoresis and capillary 
electrophoresis. Forensics has also seen the use of robotics increasing for routine 
analysis in forensic laboratories. These include the use of liquid handlers 
manufactured by companies like Hamilton and Tecan to perform routine 
laboratory techniques. Liquid handling work stations can be applied successfully 
at all levels within a forensic laboratory: DNA extraction, quantification, PCR 
setup and post PCR levels. The use of liquid handlers has helped to decrease the 
rate of errors due to human handling in forensic processing. One major advantage 
of robotic systems is the decrease in error rates as opposed to the error rate due to 
human handling. Although the time taken by robotic systems to complete the 
work is not necessarily less, the quality of the work is of a higher standard. The 
human factor can also never fully be removed or replaced, but the use of robotics 
does aid in decreasing the dependency on analysts to perform technical tasks. 
 
1.7.2. Electrophoresis 
The initial detection platforms for separation of genetic markers were labour 
intensive with a lot of time taken up by preparation and sample loading. These 
platforms were based on polyacrylamide slab-gels and silver staining (Deforce et 
al, 1998). A limitation of the earlier slab-gel method was that it did not allow for 
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overlapping of loci and therefore limited the amount of loci to be incorporated in 
multiplex systems, a limitation overcome by the latest capillary electrophoresis 
platforms incorporating the use of fluorescent labelling. 
With the advancement of capillary electrophoresis platforms, development has 
contributed to increasing output and turnaround times. It has been successful thus 
far and has allowed for more samples to be amplified simultaneously (increased 
output) and turnaround time being decreased from hours to minutes (increased 
turnaround time), compared to the gel based detection systems. Capillary 
electrophoresis instruments have also become more sensitive with lower input 
DNA concentration being required, further contributing to successful detection of 
DNA profiles. Among the companies previously mentioned is Life Technologies, 
a leading manufacturer of genetic analysis systems including capillary detection 
instrumentation. Their instruments are being used in forensic laboratories across 
the world, including South African government forensic laboratories. 
 
1.8. Statistical analysis of forensic profiles 
1.8.1. The importance of population genetics in forensics 
In forensics, the value of a match between DNA profiles is estimated using 
statistics. The strength of the match is demonstrated by calculating, through 
population genetic principles and statistical analysis, the rarity of a DNA profile 
within a population. Simply put, the rarer the occurrence of a DNA profile within 
a population, the less likely the possibility of someone else having left the DNA 
evidence at the crime scene. Reviewing the methods of evaluating the validity of a 
match is beyond the scope of this thesis. However, evaluating these indel loci for 
forensic applications are valid and it requires evaluation of forensic and 
population genetics parameters. 
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1.8.2. The basic principles of population genetics 
Population genetics is the study of allele and genotype frequencies at different 
loci, within a population and the factors that influence them (Goodwin et al, 
2011). The Hardy-Weinberg principle is based on the works of Godfrey Hardy 
and Wilhelm Weinberg and is a method which describes the relationship between 
allele and genotype frequencies within a population (Butler, 2005). Using the 
Hardy-Weinberg principle, allele and genotype frequencies can be estimated in 
the population. The Hardy-Weinberg principle requires that the population meets 
certain assumptions: 
i) Infinite population size 
ii) No natural selection has taken place 
iii) Random mating takes within the population 
iv) No mutations take place 
v) The effects of migration does not influence the population 
A naturally occurring population cannot meet all these requirements as it 
represents the qualities of a perfect population, which realistically does not exist. 
The Hardy-Weinberg equation can still be applied for estimation of allele 
frequencies and the amount of deviation from Hardy-Weinberg equilibrium within 
a population can be statistically calculated. 
To be able to apply statistical analysis to a data set, there are requirements for the 
data set and the samples used to generate it. Firstly, a population is of infinite size 
and therefore immeasurable. Because we cannot sample all individuals within a 
population, samples from individuals belonging to a specific population represents 
a sample size of that population. The minimum amount of samples required to be 
representative of a population is a minimum of 100 samples (Chakraborty, 1992). 
Secondly, individuals that form part of population sampling must be non-related. 
The diversity in the population is measured by the allele frequencies within the 
population. If the samples representing a population consists mostly of related 
individuals they will share the same alleles, and not give a true reflection of the 
population‘s diversity. 
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1.8.3. The importance of population data 
Genetic variation of populations is strongly influenced by evolution and 
geographical characteristics. These would include how isolated populations are, 
the size of populations, if there is migration between different populations and the 
ancestry and origin of individuals belonging to populations.  
There are different methods that can introduce genetic variation. Mutation allows 
for new alleles to be created and can be caused by environmental or chemical 
changes. Migration occurs when individuals from different populations move 
between populations and introduce genetic variation. Another method is sampling 
errors due to genetic drift which results in allele frequency changes in populations 
of small sample size. Genetic drift is the random change in allele frequency 
between generations in populations due to finite samples of individuals, gametes 
and alleles that contribute to the next generation (Hamilton, 2009). Genetic drift is 
caused by lack in population size increases over generations, with random change 
increasing as the population size decreases. It can also be caused by the founder 
effect, when a population is established by a small amount of individuals resulting 
in limited genetic variability despite growth in population size over generations. 
All these factors have an influence on genetic variation whether it is a positive or 
negative effect. Evolutionary and geographical changes can influence the survival 
of populations by eliminating rare genetic variants or it can influence the 
establishment of new species. 
To better understand the evolutionary and genetic changes that populations go 
through populations are studied through population genetics. Sample of 
populations are taken and population statistics are performed on the population 
data and the results analysed. Useful insights on populations can be obtained by 
studying populations in this way. 
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1.9. DNA databases 
In forensics, DNA databases have emerged as a new and powerful tool to crime 
fighting and prevention using DNA. Different DNA databases exist to fulfil 
numerous functions. Criminal DNA databases are used to detect repeat offenders. 
A criminal database would contain DNA profiles of samples collected from crime 
scenes and DNA profiles of all offenders and individuals arrested on suspicion of 
criminal involvement (arrestees). With their first offence, a criminal‘s DNA 
profile is collected and added to the criminal DNA database. Upon a second 
offence, a search on the DNA database will pick up the criminal‘s DNA profile, 
ultimately linking the offender to the crime and revealing an existing criminal 
offence. One major advantage to a criminal database is the elimination of time and 
man power in searching for a possible suspect. Criminal databases also play a key 
role in excluding possible suspects and identifying the true perpetrator of a crime. 
The first national population DNA database was a criminal DNA database 
established in the United Kingdom in April 1995 and is known as National DNA 
Database (NDNAD) (Martin, 2004; Butler, 2005). The NDNAD originally made 
use of six STR loci (vWA, D8S1179, D21S11, D18S51, THO and FGA) including 
a gender marker but there has been an addition of loci (D3S1358, D16S539, 
D2S1338 and D19S433) that has expanded the original six loci to ten loci (Butler, 
2005). After the NDNAD many population DNA databases have been established 
around the world to serve the forensic community. Other European countries have 
now established their own NDNAD or are in the process of implementing a 
NDNAD like Scotland, Denmark and Hungary, among others (Martin, 2004). 
South Africa has also realised the power of a criminal database in the fight against 
crime and legislation has recently (January 2014) been passed for the 
establishment of a criminal DNA database. 
The FBI manages CODIS which forms part of the National DNA Index System 
(NDIS) in the United States that was launched in 1998 (Budowle et al, 1998). The 
success of a DNA database is based on the amount of DNA profiles contained 
within. All fifty states within the United States are currently participating 
members that are making use of CODIS and resulting in its success. Further 
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aiding in its success is the use of thirteen core CODIS STR loci (CSF1PO, FGA, 
THO1, TPOX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, 
D16S539, D18S51 and D21S11) that are being used by participating laboratories 
in the United States. This allows for easier exchange of information and 
comparison of data between participating laboratories. Following successful 
application of CODIS, the FBI offers assistance to other countries making use of 
DNA databases. A stand-alone version of the CODIS software has been 
developed for use by other countries outside of the United States and the FBI also 
hosts a national CODIS conference, annually. Information on the CODIS system 
is available on the FBI website (http://www.fbi.gov/). 
The value of databases have been realised in assisting with across boarder crimes, 
as criminals do not necessarily operate in one area or country With this in mind, 
many of the countries with operational NDNADs have adopted the use of the 
same loci within their databases. This allows collaboration and exchange of 
information between countries. Interpol is the largest international police 
organization with its main aim to assist police around the world to work together 
to prevent crime. Interpol has also realised the value of DNA databases and have 
created a platform for countries allowing data exchange called the Interpol 
Gateway which allows countries worldwide access to their database 
(http://www.interpol.int/en). Differences in legislation and database laws exist for 
different countries. The European Network of Forensic Science Institutes (ENFSI) 
is a DNA working group that aims to bring together organisations that pursue 
forensic DNA analysis methods for the purpose of exchanging and disseminating 
information on forensic applications (www.enfsi.eu). The ENFSI makes available 
information on DNA databases relating to the database laws that exist in European 
countries. 
DNA databases can also serve a purpose in identifying missing persons or 
individuals killed in mass disasters. DNA profiles of recovered biological remains 
or unknown individuals are added to a DNA database and a subsequent search of 
possible relatives‘ DNA profiles against the DNA database can aid in locating a 
missing loved one. The application of DNA databases have been successfully 
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implemented in Spain. The database contains DNA profiles of samples donated 
voluntarily for identification of cadavers and human remains (Lorente et al, 
2002). The same purpose can be fulfilled in cases of mass disasters where large 
scale deaths make identification of the missing and deceased difficult (Alonso et 
al, 2005), as in the case of the World Trade Centre disaster and the Thai Tsunami 
of December 2004. 
DNA allele frequency databases are used in forensics to determine the occurrence 
of a DNA profile in a population. These DNA databases consist of DNA profiles 
sampled from individuals in a population with the aim of determining the 
occurrence of the alleles within the population (Butler, 2005). The identities of the 
individuals are unknown and the DNA profiles are used purely for the purpose of 
determining the allele frequencies, based on the individual‘s ethnicity. One such 
database is the United States Y-STR Database (www.usystrdatabase.org/). This 
database is used to estimate Y-STR haplotype population frequencies using 11 to 
29 Y-STR haplotypes for four populations occurring in the United States i.e. 
African American, Caucasian, Asian and Native American. Another allele 
frequency database is the Y chromosome Haplotype Reference Database (YHRD) 
(Willuweit et al, 2007). This database was established in 1999 and provides Y-
STR haplotype frequencies for populations worldwide as well as assessment of 
male population stratification based on Y-STR haplotype frequencies. 
 
1.10. DNA forensics in South Africa 
Crime statistics was released by the South African Police Service (SAPS) in 
September 2014 (www.saps.gov.za). The crime figures in South Africa do not 
create a positive picture with specific types of crime continuing to be on the 
increase, placing pressure on SAPS and the Criminal Justice System. 
Currently all criminal forensic case work is being processed by the South African 
Police Service‘s Division Forensics at their forensic science laboratories across 
the country. The SAPS allele frequency database is managed by SAPS Forensics 
Science Laboratories. This database was established by using convenience 
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samples that represent the four South African populations (Caucasian, Black, 
Coloured and Asian). It is used to perform statistical calculations, to determine 
how rare a DNA profile is in the South African populations. The allele frequency 
database also contains DNA profiles obtained from volunteers and is not a 
criminal DNA database. 
In September 2009 the Office for Criminal Justice System Reform made 
recommendations relating to a forensic DNA database allowing for the 
establishment of a criminal DNA database containing DNA profiles collected 
from suspects arrested for criminal activity. The criminal DNA database would be 
known as the National Forensic DNA Database (NFDD) and the main aims of the 
database are: 
i) to serve as a criminal investigative tool; 
ii) identify repeat offenders; 
iii) assist in proving the innocence or guilt of accused individuals and 
iv) assist in identification of human remains and missing persons. 
The Portfolio Committee on Police consists of members of Parliament‘s National 
Assembly. The purpose of a portfolio committee is to consider bills, deal with 
departmental budget votes and oversee and make recommendations on the 
specific department they are responsible for. The Portfolio Committee on Police 
consulted with various entities including the National Prosecuting Authority and 
Department of Justice and Constitutional Development during drafting of the 
DNA Bill as well as embarking on a visit to Canada and the United Kingdom in 
an effort to familiarise themselves with issues relating to the DNA legislation. In 
April 2013 the Criminal Law (Forensic Procedures) Amendment Act [B9-2013] 
was approved by Cabinet and on 12 November 2013 the DNA Act was approved 
by the National Assembly. On 27 January 2014 the Criminal Law (Forensics 
Procedures) Amendment Act 37 of 2013 (DNA Act) was passed into law 
(Government Gazette, 2014). 
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The financial cost of implementing the DNA Act is high with training of police 
officials and forensic awareness programmes only, calculated to be approximately 
R22 million.  
Despite the high financial cost to the South African government, establishment of 
the NFDD will prove to be a worthwhile investment in combatting crime in South 
Africa. 
 
1.11. South African population 
South Africa has a rich and colourful history which is deeply rooted in South 
Africa‘s people and their heritage. South Africa‘s population consists of different 
and a wide variety of languages. The different population groups within the South 
African populations originate from all over the world with the Afrikaner group 
being from French, Dutch and German descend and the Coloured population 
being an admixed group of Khoisan, Bantu, Asian and European ancestry. 
The first people responsible for South Africa‘s diversity were the Khoisan people, 
also known as the Bushmen and Hottentots. They were hunter-gatherers who 
hunted using bow and arrow and lived off the land. The Khoisan people are sadly 
on the brink of extinction. They are being driven from their ancestral land and 
prevented from hunting. 
The first Europeans to arrive in South Africa were European settlers from Britain 
and Netherlands. The Dutchman Jan Van Riebeeck arrived in the Cape of Good 
Hope in 1652 bringing with him his crew of ninety men. His purpose was to build 
a fort to supply Dutch ships. The White South African population of today are 
descendants from these European settlers. 
The Coloured people are also referred to as people of mixed race and are found to 
reside predominantly in the Western Cape. The Coloureds originated from 
admixture between the Khoisan, Bantus, Europeans and slaves that the European 
settlers brought to South Africa. These slaves were brought from Madagascar and 
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South East Asia. Immigration was also encouraged which resulted in Indian and 
Chinese labourers establishing themselves in South Africa during the 1600s. 
The largest population group that make up the South African population is the 
Black Africans known collectively as the Bantu who are descendants from Black 
Africans who took part in the Bantu expansion from South East Nigeria and 
Western Cameroon by A.D. 300 (Montano et al, 2011). The Bantu people consist 
of different ethnic groups which include Zulu, Xhosa and Tswana and speak 
different Bantu languages. They are followed by the Coloured, White and Indian 
population groups, respectively. This colourful mix of different ethnicity, cultures 
and religions makes up South Africa‘s ‗rainbow nation‘ as originally referred to 
by Archbishop Desmond Tutu, when he referred to the post-Apartheid South 
African population. 
From the last census conducted in 2011, South Africa‘s population was estimated 
at 51.8 million (Statistics South Africa, 2011). Black Africans make up 79.2 % of 
South Africa‘s population, Coloureds make up 8.9 % and Whites also make up 8.9 
% with Indian Asians consisting of 2.5 %, with individuals not falling within the 
four groups being classified as ―Other‖, making up 0.5 %. 
The distribution of the populations in South Africa is illustrated in figure 1.3. The 
largest population group, the Black Africans can be seen to populate the major 
part of South Africa. The Coloured group is settled mainly in the Western and 
Northern Cape with the other racial groups i.e. Indian-Asian and White, found 
throughout South Africa. 
 
1.12. Objectives of the project 
The main objective of the present study was to evaluate the performance of the 
Qiagen
®
 Investigator DIPplex kit for forensic application in South Africa. Firstly, 
the properties of the the Qiagen
®
 Investigator DIPplex kit was evaluated by 
investigating the sensitivity, reproducibility and robustness of the kit. Secondly, 
the 30 loci in the Qiagen
®
 Investigator DIPplex kit were evaluated in five South 
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African populations i.e. the Afrikaner, Mixed Ancestry, Indian-Asian and Bantu 
(Xhosa and Zulu) populations by estimating allele frequencies, forensic and 
population parameters to give valuable insights into the application of this kit in 
South Africa. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3. Distribution of the different population groups within South Africa 
based on their location within South Africa. 
(Image from http://en.wikipedia.org/wiki/Ethnic_groups_in_South_Africa data 
provided by Stats SA)  
 
Dominant population groups in South Africa. 
    Black African 
    Coloured 
    Indian or Asian 
    White 
    None dominant 
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Chapter 2 
Evaluation of the sensitivity, reproducibility and robustness of the Qiagen 
Investigator DIPplex kit and generating population data for five South 
African populations 
 
2.1. Introduction 
For a PCR amplification system it is of vital importance to perform optimisation. 
Through optimisation it can be determined how the different elements that make 
up a system performs together to deliver maximum results at minimum costs. This 
includes optimisation of reagents and instrumentation. For a PCR system used for 
forensic purposes it is of even more importance to perform optimisation. The 
types of samples usually encountered in forensics are degraded DNA samples and 
DNA samples of small quantities. Therefore the PCR system is normally highly 
sensitive to ensure maximum detection and amplification of the DNA. Although 
increased sensitivity is an advantage for analysis of forensic samples, it is also a 
disadvantage as this also allows detection and PCR amplification of non-specific 
DNA, increasing the chances of DNA contamination (Sundquist and Bessetti, 
2005; Champlot et al, 2010). Optimisation also means optimising the laboratory 
environment in which the work will be done. Again, due to the sensitivity of the 
PCR system used in forensics, the laboratory setup has a big impact on the quality 
of the work. Sharing of instrumentation and reagents like pipettes may be a 
potential contamination source. Inconsistency in decontamination and practical 
application of laboratory techniques among laboratory staff will allow potential 
contamination and make it difficult to detect and eliminate the source of 
contamination.  
For the current project, a population dataset was generated to determine the 
occurrence of 30 indel alleles of the Qiagen
®
 Investigator DIPplex kit 
representative of five South African populations (Afrikaner, Mixed Ancestry, 
Indian-Asian, Xhosa and Zulu subpopulations). 
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This chapter will investigate the multiplex PCR amplification system used in this 
study and the generation of the population dataset for the 30 indel alleles of the 
Qiagen
®
 Investigator DIPplex kit. 
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2.2. Materials and methods 
2.2.1. Contamination preventative measures and good lab practices 
To limit possible contamination, a separate laboratory area was identified for the 
purpose of PCR amplification setup. UV lights were installed above the work 
benches and connected to timers to switch on daily at a specified time, for 
overnight exposure. A laminar flow was installed for the setup of PCR 
amplification. Extra attention was given to wearing full personal protective 
equipment namely gloves, lab coat, hair net and face mask. All work surfaces 
were decontaminated with a 5 % bleach solution before and after PCR setup. 
Gloves were changed regularly. Only filtered tips were used and all consumables 
were in a sealed condition before being opened and utilized. Samples were 
handled one at a time to prevent cross contamination. All gloves and tips were 
disposed of appropriately. Pipettes, tubes and filter tips were regularly exposed to 
UV light to further aid in contamination prevention. 
The presence of contamination is indicated by the presence of amplification in the 
negative control and possibly by any additional peaks in the positive control. The 
data from any PCR batch where there were indications of contamination is 
excluded and PCR experiments repeated. 
 
2.2.2. Sample collection and DNA extraction methods 
To investigate the effect of different DNA extraction methods on the quality of 
the DNA results, DNA was extracted using two different DNA extraction 
methods: DNA extraction from buccal swabs and DNA extraction from whole 
blood (See below). 
 
The South African populations investigated in this project consist of five 
population groups: Afrikaner, Mixed Ancestry (Coloured), Indian-Asian, Xhosa 
and Zulu (collectively referred to as Bantu). Samples were collected from 101 
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Afrikaner individuals, 104 Mixed Ancestry individuals, 102 Indian-Asian 
individuals, 102 Xhosa individuals and 103 Zulu individuals, with ethical 
approval granted from the Ethics committee of the University of the Western 
Cape (UWC). Whole blood samples were obtained from Western Province Blood 
Transfusion Services for individuals belonging to the Afrikaner populations, 
Mixed Ancestry populations and Asian Indian populations. Buccal (oral) swabs 
were collected from the Xhosa and Zulu populations, from the campus of the 
University of the Western Cape. 
The ethnicity of study participants was determined using a process of self-
classification, going as far back as three generations. To determine the correctness 
of the self-classification process participants were interviewed by laboratory staff 
members, with possible admixed individuals being excluded. 
 
2.2.2.1. DNA extraction 
2.2.2.1.1. DNA extraction from buccal swabs 
DNA from buccal swabs was extracted using the Proteinase K and salting lysis 
extraction method (Medrano, 1990). The comprehensive protocol of the extraction 
method is presented in the appendix. The extracted DNA samples were stored at 
 -20 
o
C. 
 
2.2.2.1.2. DNA extraction from whole blood 
DNA extraction from whole blood was performed using the Lahiri and 
Nurnberger (1991) extraction method. The comprehensive protocols of both 
methods are presented in the appendix. The extracted DNA samples were stored 
at -20 
o
C. 
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2.2.3. DNA quantification 
DNA samples were quantified using the Nanodrop ND-1000 (Coleman 
Technologies Inc.) and the Nanodrop 2000 (Thermo Scientific). Absorbance 
readings at 230 nm, 260 nm and 280 nm were determined. Three samples were 
diluted to 0.1 ng/µL, 0.2 ng/µL and 0.5 ng/µL. 
 
2.2.4. PCR amplification 
Using buccal samples and samples from whole blood, PCR amplification was first 
performed as per manufacturer‘s recommendations. Amplification was performed 
in a final volume of 25 µL containing 2 µL 0.1-1.0 ng DNA, 5 µL Reaction Mix 
A, 5 µL Primer Mix DIPplex, 0.6 µL Multi Taq2 DNA Polymerase and 12.4 µL 
SABAX water (Qiagen, 2011). 
PCR amplification was then repeated in a final volume that was half of the 
manufacturer‘s recommendations. Amplification took place in a final volume of 
12.5 µL containing 2.5 µL 0.1-1.0 ng DNA, 2.5 µL Reaction Mix A, 2.5 µL 
Primer Mix DIPplex, 0.3 µL Multi Taq2 DNA Polymerase and 5.2 µL SABAX 
water. 
Lastly, amplification was performed in a final volume of 10 µL with 40 % of the 
manufacturer‘s conditions. Amplification took place in a final volume of 10 µL 
containing 2 µL 0.1-1.0 ng DNA, 2 µL Reaction Mix A, 2 µL Primer Mix 
DIPplex, 0.24 µL Multi Taq2 DNA Polymerase and 3.76 µL SABAX water. 
Thermo cycling was conducted in a Veriti 96-well Thermal Cycler (Life 
Technologies) and Arktik
™
 Gradient Enabled 96-well Thermal Cycler (Thermo 
Scientific). Thermo cycling conditions as recommended by the manufacturers 
were followed: 94 
o
C for 4 minutes, 94
 o
C for 30 seconds, 30 cycles at 61
 o
C for 
120 seconds, 68
 o
C for 60 minutes and a holding step at 10
 o
C. Samples were 
stored at -4 
o
C. 
A negative control and a positive control were included with each round of PCR 
amplification. A volume of 2 µL SABAX water was added as a negative control. 
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A volume of 1 µL Control DNA XY5 serving as a positive control, as provided in 
the Qiagen
®
 Investigator DIPplex kit, of the working stock solution in addition to 
1 µL SABAX water was added. 
Amplification of samples for the purpose of constructing a reference database was 
performed using the amplification protocol consisting of a final volume of 10 µL 
and thermo cycling conditions as recommended by the manufacturer. Optimal 
DNA concentration for input DNA was determined to be between 0.2 to 0.3 ng. 
PCR amplification was performed using input DNA of 0.2 ng for samples 
extracted from buccal samples and whole blood. 
 
2.2.5. Evaluation of DNA concentration sensitivity 
The DNA concentration range as recommended by the manufacturers is  
0.2 - 0.5 ng with reliable results obtained for concentrations less than 0.1 ng 
during internal validations (Qiagen, 2011). To evaluate the system‘s sensitivity to 
different input DNA concentrations and to determine the optimal input DNA 
concentration for performing PCR amplification, three different input DNA 
concentrations were used during PCR amplification i.e. 0.1 ng/µL, 0.2 ng/µL and 
0.5 ng/µL. PCR amplification was performed using three samples extracted from 
buccal swabs, the positive and a negative control, in a final volume of 25 µL as 
per manufacturer‘s recommendations and a final volume of 12.5 µL that was half 
of the manufacturer‘s recommendations. The impact of the different input DNA 
concentrations on heterozygote peak imbalance was also evaluated. 
 
2.2.6. Evaluation of the robustness and reproducibility 
To investigate the robustness and reproducibility of the system, PCR 
amplification was tested in two samples, the positive and a negative control, in 2X 
PCR duplicates, using the three final volume experimental conditions indicated in 
section 2.2.4. 
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2.2.7. Capillary Electrophoresis 
PCR amplified product was prepared for capillary electrophoresis by loading 1 µL 
unpurified PCR amplicon in a 96 well PCR plate. A cocktail consisting of size 
standard and HiDi formamide was prepared by adding 0.3 µL DNA size standard 
550 (BTO) (Qiagen) and 8.7 µL HiDi formamide together, per sample. The 
cocktail of HiDi formamide and size standard was mixed using the pipette and 
spun down. A final volume of 9 µL cocktail was loaded to the 1 µL unpurified 
PCR product. The samples were denatured at 95 
o
C for 5 minutes in the Veriti  
96-well Thermal Cycler (Life Technologies) and snap cooled on ice. Capillary 
electrophoresis was performed on a 3500 Genetic Analyzer (Life Technologies). 
 
2.2.7.1. Allelic ladder 
An allelic ladder is a DNA sample consisting of all possible alleles. It is used for 
correct sizing of DNA fragments. A volume of 1 µL allelic ladder DIPplex 
(Qiagen) was loaded with each batch of samples prepared for capillary 
electrophoresis. A cocktail consisting of size standard and HiDi formamide was 
prepared by adding 0.3 µL DNA size standard 550 (BTO) (Qiagen) and 8.7 µL 
HiDi formamide together, per sample. The cocktail of HiDi formamide and size 
standard was mixed using the pipette and spun down. A volume of 9 µL of size 
standard/ formamide cocktail was added to the allelic ladder. 
 
2.2.7.2. Data Collection and Data Analysis 
Data was collected using the 3500 data collection software v1.0 (Life 
Technologies). Data analysis and allele designation was performed using the 
Qiagen
®
 Investigator DIPplex template files (Qiagen) and the Genemapper® ID-
X software v1.2 (Life Technologies). 
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2.2.8. DNA profile quality 
The quality of the DNA profiles was assessed by looking at peak height, peak 
height ratio, allele designation and overall DNA profile quality. For analysis 
performed using Genemapper® ID-X software v1.2 (Life Technologies), quality 
settings according to the manufacturer was used which includes the following 
criteria: a minimum peak height for homozygous samples of 200 relative 
fluorescent units (rfu) and 100 rfu for heterozygous samples; maximum peak 
height of 5000 rfu; minimum peak height ratio of 0.7 for heterozygote samples. 
 
2.3. Results 
2.3.1. Evaluation of DNA extraction methods 
DNA extracted from buccal swabs and whole blood, using two different 
extraction methods, was used to perform PCR amplification in a final volume of 
10 µL with 40 % of the manufacturer‘s conditions. The DNA quality and quantity 
was evaluated by assessing the absorbance readings ratios 260/280 determined in 
Section 2.2.3. A 260/280 ratio in the range of 1.8 is indicative of good DNA 
purity. Readings lower than this expected value may be indicative of the presence 
of contaminants. 
On average the 260/280 ratio for DNA extracted from whole blood was higher 
than 1.8 compared to the 260/280 ratio for DNA extracted from buccal samples. 
The DNA concentration readings for DNA extracted from buccal samples was 
lower overall when compared to DNA extracted from whole blood. However, 
DNA profiles obtained from both DNA extraction methods still resulted in good, 
usable DNA profiles despite the differences in the DNA quality. No PCR 
amplification was detected in the negative controls, indicating absence of 
contamination. Figure 2.1 shows an example of an electropherogram depicting the 
DNA profile of the DNA XY5 positive control provided in the Qiagen
®
 
Investigator DIPplex kit generated using 10 µL with 40 % of the manufacturer‘s 
conditions. 
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2.3.2. Evaluation of DNA sensitivity 
Sensitivity was evaluated by looking at the DNA profile quality characteristics as 
listed section 2.2.5. PCR amplification using input DNA of 0.1 ng proved to be 
insufficient, resulting in DNA profiles of poor quality and incomplete profiles 
with allelic dropout (Figure 2.2). Input DNA of 0.2 ng to 0.3 ng resulted in DNA 
profiles of better quality consisting of amplification of all 30 loci (full DNA 
profiles) and good peak morphology (Figure 2.3). DNA quality and concentration 
of input DNA had a big effect on the DNA profiles obtained. A high 
concentration of input DNA (0.5 ng and higher) resulted in off scale peaks and in 
some cases, no profiles being visible due to the peaks being above the detection 
level of the 3500 Genetic Analyzer (Life Technologies) (see section 2.2.8) as well 
as massive peak imbalance. The fine balance of the system was demonstrated as 
too much input DNA affected capillary electrophoresis resulting in off scale peaks 
and pull up peaks (Figure 2.4). Samples extracted from whole blood delivered 
overall better quality DNA profiles than samples extracted from buccal samples. 
Heterozygote peak imbalance was observed across all three concentrations tested, 
with allelic dropout observed in samples using input DNA of 0.1 ng and allelic 
drop in observed in samples using input DNA of 0.5 ng and higher. In samples 
using input DNA in the range of 0.2 - 0.3 ng heterozygote peak imbalances were 
also observed however it was not high enough to impact allele calling and 
interpretation. 
 
2.3.3. Evaluation of the robustness and reproducibility 
The two samples and the positive control were successfully amplified using the 
three PCR amplification protocols. All 30 loci were amplified using the three PCR 
protocols (not shown). No differences in the results obtained from the two 
different thermal cyclers were observed. The DNA profile generated using the 
three protocols were identical showing that the system is robust and results were 
reproducible. 
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2.3.4. Sample data 
No PCR amplification was detected in the negative controls, indicating absence of 
contamination. 
2.4. Summary 
The PCR system was successfully evaluated for a template DNA within the range 
of 0.1 ng to 0.5 ng, depending on the DNA quality of the input DNA. The profiles 
produced with DNA within the range of 0.2 ng to 0.3 ng were determined to be 
reproducible and robust. Full DNA profiles were obtained with amplification at all 
30 indel loci, for both buccal and blood samples.  
The effect of DNA extracted using different DNA extraction methods 
demonstrated the effect DNA quality has on the DNA profiles but that the system 
was sensitive enough to generate DNA profiles of usable quality by adjusting the 
concentration of input DNA. Samples extracted from whole blood delivered 
samples of better DNA quality than samples extracted from buccal samples with 
higher purity and higher yield of DNA concentration. Samples extracted from 
whole blood resulted in sample profiles of higher overall quality than samples 
extracted from buccal samples, using the PCR protocol of 10 µL final volume 
with 40 % manufacturer‘s recommendations with input DNA in the range of  
0.2 ng - 0.3 ng. 
For samples extracted using both extraction methods, the DNA input range of  
0.2 ng - 0.3 ng proved to be sufficient for generating profiles of good quality. 
DNA input concentrations outside the range of 0.2 ng- 0.3 ng resulted in loss of 
quality.  
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Figure 2.1 An electropherogram of a DNA profile obtained from the positive control DNA XY5 using 10 µL with 40 % of the 
manufacturer‘s conditions. 
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Figure 2.2 An electropherogram of a DNA profile obtained with input DNA of 0.1 ng. OL = Off Ladder 
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Figure 2.3 An electropherogram of a DNA profile obtained from with input DNA of 0.2 ng in a final volume of 10 µL. 
. 
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Figure 2.4 An electropherogram of a DNA profile obtained from with input DNA of > 0.5 ng. OL = Off Ladder 
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All three PCR protocols evaluated proved to be successful in delivering usable 
results for DNA input concentration of 0.2 ng. This concentration was within the 
manufacturer recommended concentration range of 0.1 - 0.5 ng. 
 
Despite the the Qiagen Investigator DIPplex kit already being optimised, I would 
recommend further evaluation and adaptation of the system to suit specific 
research requirements which would include consideration of DNA quality as a 
result of different DNA extraction methods. Due to the high sensitivity of the 
system, careful attention needs to be given to contamination preventative 
measures. These would include the basic decontamination method, good 
laboratory practices and restricting communal use of laboratory instruments like 
pipettes (see section 2.2.1). 
Based on the above evaluations, the conditions for generating population data 
using samples from both extraction methods were as follows: DNA input 
concentration range of 0.2 ng to 0.3 ng using the PCR protocol consisting of a 
final volume of 10 µL (using 40 % manufacturer‘s recommendations), shown in 
the next chapter. 
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Chapter 3 
Investigation of the presence of a null allele at HLD97 locus 
 
3.1. Introduction 
The presence of null alleles has been reported in humans and in other species 
(Paetkau and Strobeck, 1995; Pemberton et al, 1995; Neumann and Wetton, 
1996). A null allele refers to an allele that repeatedly fails to PCR amplify at a 
locus due to unsuccessful primer binding (Dakin and Avise, 2004). During this 
study lack of PCR amplification was observed at HLD97 locus in six samples 
from the Xhosa population and eight samples from the Zulu population. For six 
samples from the Xhosa population and eight samples from the Zulu population 
successful amplification was achieved at all loci except the HLD97 locus; neither 
the HLD97 insertion nor deletion allele was amplified. The DNA result obtained 
for these 14 samples from the Bantu populations at all the other loci were of good 
quality with peak heights well over 100 rfu and good peak morphology observed. 
Therefore the possibility of this result being obtained by chance, allelic dropout or 
poor DNA quality was discarded. It is hypothesized that the possible presence of a 
null allele is responsible for the lack of PCR amplification at the HLD97 locus. 
To investigate the possible presence of a null allele at the HLD97 locus, the 
following strategies were applied. One cause of null alleles is unsuccessful primer 
binding which is due to variations in the nucleotide sequence within the primer 
binding site. Therefore two tests were performed to investigate this. Firstly, the 
binding properties of the manufacturer‘s primers for the HLD97 locus were 
investigated by performing PCR amplification using a lower annealing 
temperature, which decreases the primer binding stringency. The second test was 
to perform DNA sequencing and sequence alignments on selected samples and 
comparison to the Genbank sequence (Benson et al, 2013) to establish the 
presence of any nucleotide differences that could lead to the primer binding 
failure and consequently, unsuccessful PCR amplification. The selected samples 
were (1) samples for which unsuccessful PCR amplification was observed at 
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HLD97, and (2) samples representing the other genotypes observed, i.e. 
homozygote for the deletion allele, homozygote for the insertion allele, 
heterozygote for the deletion and insertion alleles and homozygote for the null 
allele, for comparison purposes. Lastly, statistical analysis was performed to 
determine null allele frequencies and to establish possible consequences of the 
presence of the HLD97 null allele on the populations. 
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3.2. Materials and methods 
3.2.1. Samples selection 
Generation of population profiles for the five populations was performed as 
previously described (section 2.2.4.1.). Successful amplification was observed at 
all loci except the HLD97 locus with neither the HLD97 insertion nor deletion 
allele being amplified in 14 Bantu (N=6 Xhosa) and N=8 Zulu) samples. 
One sample from each Bantu population (N= 1 Xhosa and N= 1 Zulu) was chosen 
to represent each of the four genotypes namely homozygote for the deletion allele, 
homozygote for the insertion allele, heterozygote for the deletion and insertion 
alleles and 4X homozygotes for the null allele (N=2 Xhosa and N=2 Zulu), based 
on their observed phenotypes through fragment analysis. An insertion 
homozygote individual carries the insertion allele, a 14 bp sequence  
(5‘- AGAGAAAGCTGAAG-3‘) in both chromosomes. A heterozygote individual 
carries both the insertion and deletion allele. The positive control as provided in 
the kit is a heterozygote for the deletion and insertion alleles and was also 
included in sequencing analysis performed. For statistical analysis of the HLD97 
null allele, samples from all five populations (Afrikaner, Mixed Ancestry, Indian 
Asian, Xhosa and Zulu) were used. No samples containing the HLD97 null allele 
were excluded. 
 
3.2.2. Investigating the primer binding properties of the Investigator DIPplex 
HLD97 primers (Qiagen) 
To investigate the primer binding stringency of the manufacturer‘s Investigator 
DIPplex primers (Qiagen), N= 4 (see above) null allele homozygote samples were 
PCR amplified at a lower annealing temperature. PCR amplification was 
performed as previously discussed (section 2.2.8). Thermocycling conditions as 
recommended by the manufacturers were followed, with the annealing 
temperature of the primers adjusted to 5
 oC lower than the manufacturers‘ 
recommended annealing temperature of 61
 o
C. 
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3.2.3. Primer design and PCR amplification 
The accession number rs17238892 was used to obtain the reference sequence 
from Genbank (Figure 3.1). A primer pair consisting of a forward and reverse 
primer was designed for the purpose of PCR amplification of a DNA sequence 
containing the HLD97 indel site (Table 3.1) using the primer design software 
Oligo 1.4 Primer Analysis Software (Rychlik, 2007) and the Genbank reference 
sequence. Primers were designed taking into consideration the percentage guanine 
and cytosine, primer length, melting temperature (Tm) and annealing temperature 
(Ta).The primers were designed for PCR amplification of a 527 bp amplicon with 
the forward primer binding site being 349 bp from the indel site and the reverse 
primer being 123 bp from the indel site. Primers were supplied by Integrated 
DNA Technologies (IDT), Whitehead Scientific. The optimal primer annealing 
temperature was determined empirically by gradient PCR. Two reference 
samples, a negative control and the positive control were PCR amplified for this 
purpose. 
Table 3.1 PCR primer set and sequences used for amplification of a selected 
region of the HLD97 indel. 
Primer 
Sequence 
Product 
Size (bp) 
%GC 
Tm 
(
o
C) 
Ta 
(
o
C) 
 
HLD97FWD 
 
5'- AAGGCAAATCGTGATTGTGAC-3' 
 
527 
 
43 
 
60 
 
62 
HLD97REV 5'- ACACACCAGCAATGAGTGTCC-3' 52 64 62 
bp, base pairs; %GC, percentage Guanine and Cytosine; Tm, melting temperature; Ta, annealing 
temperature; 
o
C, degrees Celsius. 
 
3.2.4. PCR amplification 
3.2.4.1. PCR amplification for primer optimisation 
PCR amplification was performed in a final volume of 20 µL consisting of 2 ng  
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Figure 3.1.The reference sequence obtained from Genbank (rs17238892) with the nucleotide position (in bp) indicated in bold. The 
HLD97 indel site is located between 31328384 and 31328385. The region containing the HLD97 indel site is highlighted in yellow. The 
forward and reverse primer position is highlighted in blue. 
 
>gi|224589804:31328000-31328884 Homo sapiens chromosome 13, GRCh37.p13 Primary Assembly 
 
31327999...GGAGCAGAAT.....CATTCAGATG.....GTATAACATA.....AGGAAAAACT.....TTGCCCAAGG.....CAAATCGTGA.....TTGTGACAGC 
31328069...TTTGTGATTT.....TTAGAGAATA.....GCATGGGCCA.....GGCACAGTGG.....CTCATGCCTG.....TAATCCCAGC.....ACTTTGGGAG 
31328139...GCCGAGGCAG.....GCAGGTCACT.....TGAGGTTGGG.....AGTTCGACAA.....CAGCCTGACC.....AACATGGAGA.....AACCCTGTCT 
31328209...CTACTAAAAA.....TACAAAATTA.....GCTGGGCGTG.....GTGGTGCATG.....CCTGTAATGC.....CAGCTACTCG.....GGAGGCTGAG 
31328279...GCAGGAGAAT.....CACTTAAACC.....TGGGAGGCGG.....AGGTTGCGGT.....GAACCAAGAT.....AGCACCATTG.....CACTCCAGCC 
31328349...TGGGCAACAA.....GAGTGAAACT.....CCGTCTCAAA.....AAGAGTTCAC.....AGTTTCTCTT.....TTGCTTTGAT.....TTTCTTATCT 
31328419...GCCGGATAAC.....AATAGTATTT.....TGGAAGGCAG.....GAGGAATTGT.....GGAAAGAAAT.....GGGTTTTGGG.....GAGTGGCTGA 
31328489...TTGGAGGCAA.....ATCCAAGGAC.....ACTCATTGCT.....GGTGTGTGAC.....TCCAGGCAGT.....TACTCAGCTT.....TTCCAAGCCT 
31328559...CAGTTTCCTT.....ATTGTAAAAC.....AGGACCATGG.....TCTAGCTAGT.....AGCATTCCTA.....TGGTGAGTGA.....AATAATATGT 
31328629...ATAAAGCTCC.....TGACACAGTG.....CTTGGCATAT.....ATCAGATTGA.....GCCATGTAAA.....ACTGCCAATA.....TCTGGCTATT 
31328699...TATGACCTAC.....AAAAATAGCA.....TTTCATATGA.....TTCCACCTAA.....CATCTGAAGC.....GCAATAAATG.....TTATTATTGA 
31328769...TAATGCAGGT.....GGTGGTGATA.....AAGTTTTGAA.....ATCAGAAAGA.....CCTGGCTTCA.....AATTCCACGC.....CTTCACTGGC 
31328839...CTGACTTATT.....TTCATTCATT.....TGACAAATAT.....TATTTTGAAC.....ACCCC 
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DNA, 2 µL S-T GOLD buffer (1X), 2 µL dNTPs [0.2 mM], 2 µL Ultrapure BSA 
[0.4 mg/µL] (Ambion
®
), 0.2 µL Super Therm GOLD Taq polymerase [0.05 U],  
2 µL forward primer [0.3 µM], 2 µL reverse primer [0.3 µM] and 7.8 µL SABAX 
water. Thermo cycling was conducted in an Arktik
™
 Gradient Enabled 96-well 
Thermal 
Cycler (Thermo Scientific). The thermo cycling conditions were 94
 o
C for  
10 minutes, 35 cycles at 94
 o
C for 40 seconds, Tm range from 58
 o
C to 66
 o
C for  
45seconds and 72
 o
C for 45 seconds, 60
 o
C for 45 minutes and a holding step at  
10
 o
C. 
 
3.2.4.2. PCR amplification of a DNA fragment containing the HLD97 indel 
site 
PCR amplification was performed in a final volume of 30 µL consisting of 2 ng 
DNA, 3 µL S-T GOLD buffer (1X), 3 µL Ultrapure BSA [0.4 mg/µL] (Ambion
®
),  
3 µL forward primer [0.3 µM], 3 µL reverse primer [0.3 µM], 0.3 Super Therm 
GOLD Taq polymerase [0.05 U], 3 µL of dNTP mix [0.2 mM] and 12.7 µL 
SABAX water. Thermo cycling was conducted in a Veriti 96-well Thermal Cycler 
(Life Technologies) and Arktik
™
 Gradient Enabled 96-well Thermal Cycler 
(Thermo Scientific). Thermo cycling conditions were as follows: 94 
o
C for  
10 minutes, 35 cycles at 94
 o
C for 40 seconds, 60.1
 o
C for 5 seconds and 72 
o
C for 
45 seconds, 60 
o
C for 45 minutes and a holding step at 10
 o
C. Samples were stored 
at -4 
o
C. 
 
3.2.5. Agarose gel electrophoresis 
Success of PCR amplification was checked by loading the PCR products on a 1 % 
agarose gel (see Appendix). A volume of 1 µL PCR product was mixed using a 
pipette with 4 µL loading dye (Bioline) that has been pre-mixed with GelRed
®
 
Nucleic Acid Stain (Biotium) before loading onto the agarose gel. A volume of  
1 µL of the negative control, positive control and Hyper Ladder V (Bioline) each 
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was loaded and run in addition to the PCR amplicon samples. Gel electrophoresis 
was performed on a GEL XL Ultra V-2 (Labnet Intl, Inc.) at 25 V for 25 minutes. 
Following gel electrophoresis an image was captured using an Alphamager
®
 HP 
Gel Imager. 
 
3.2.6. Capillary Electrophoresis 
Capillary electrophoresis was performed as previously described (section 2.2.7). 
 
3.2.7. Data Collection 
Data collection was performed as previously described (section 2.2.7.2). 
 
3.2.8. DNA Sequence Analysis 
3.2.8.1. DNA sequencing 
DNA sequencing is a method of determining the nucleotide order of a DNA 
molecule. Using dideoxynucleoside triphosphates (ddNTPs) and a denatured 
DNA strand as a template, new DNA strands are synthesised through strand 
elongation. Sanger DNA sequencing is a method of DNA sequencing that was 
developed by Frederick Sanger in 1975. It incorporates chain-terminating ddNTPs 
by DNA polymerase. 
The DNA nucleotide sequence information of the selected samples was 
determined by Sanger DNA sequencing to confirm the genotypes of the 
heterozygote-, deletion homozygote- and insertion homozygote samples and to 
investigate the possible presence of nucleotide variations occurring in the primer 
binding sites of the null allele homozygote samples. 
The forward and reverse primers used for PCR amplification were also used for 
Sanger DNA sequencing. The PCR amplified DNA samples and primers were 
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submitted to Macrogen Inc. (Netherland) for PCR purification and Sanger DNA 
sequencing. 
 
3.2.8.2. Sequencing data analysis 
DNA sequencing results were obtained from Macrogen Inc. (Netherland). The 
chromatograms were visualised using BioEdit software (Hall, 1999), Chromas 
Lite software 2.1 (http://www.technelysium.com.au) and FinchTV software 
(www.geospiza.com/finchtv). 
 
3.2.8.3. Sequence alignments 
Consensus sequences were constructed using the forward and reverse sequence 
reads using BioEdit software (Hall, 1999). Multiple consensus sequence 
alignments were constructed using BioEdit software (Hall, 1999) along with the 
reference sequence obtained from Genbank using the accession number/SNP ID 
(rs17238892) (Qiagen, 2011). Sequence alignments were also performed with the 
HLD97 null allele sequences and the Genbank reference sequence. Sequence 
alignments were not performed with heterozygous individuals due to the presence 
of both alleles which results in mixed traces, making base pair assignments 
difficult. 
3.2.9. Statistical data analysis of the HLD97 null allele 
3.2.9.1. Estimation of HLD97 null allele frequencies 
Null allele frequencies were calculated using five methods: 
i) the Hardy-Weinberg equation  
1 = p
2
 +2pq +q
2
 
where p and q represent the allele frequencies of the two alleles at the a locus with 
q
2 
representing the D97 null allele. By taking the frequency of the null allele 
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homozygote individuals in a population and calculating the square root of that 
frequency, an estimate of the null allele frequency is calculated. 
 
ii) a null allele frequency estimator Chakraborty et al (1992): 
r = (He – Ho) / He + Ho) 
Chakraborty et al‘s null allele estimator is based on the assumption that any 
missing data is due to failed amplification as a result of degraded DNA, etc. or 
due to the presence of a homozygous null allele. 
 
iii) null allele estimator 1 by Brookfield (1996): 
r = (He – Ho) / (1 + He) 
where r is null allele frequency, He is expected heterozygosity calculated as the 
sum of the product of all observed allele frequencies (∑    , with i≠j) and Ho is 
observed heterozygosity calculated as n2 / (n1+n2) with n1 being the number of 
one-banded individuals and n2 the number of two-banded individuals. This null 
allele estimator is applied under the assumption that no null allele homozygotes 
are present and ignores all non-amplified samples as degraded DNA or human 
error. 
iv) null allele estimator 2 by Brookfield (1996): 
r = A + √                   
in which A = He(1 + N) - Ho, and B = 4N (1 - He
2
). Here, the observed 
heterozygosity (Ho) is measured from the data as n2 / (n1 + n2), where n1 is the 
number of one-banded individuals and n2 is the number of two-banded 
individuals in the sample. N represents the proportion of samples not amplified 
due to a null allele presence. The expected heterozygosity (He) is calculated as the 
 
 
 
 
 52 
 
sum of the product of all observed allele frequencies (∑    , with i≠j). This null 
allele estimator does acknowledge the presence of null allele homozygotes. 
 
v) ML-NullFreq software program (Kalinowski and Taper, 2006). This program 
uses a maximum likelihood estimator that is based on actual genotype counts and 
not allele frequencies. It is not based on the presence or absence of data: 
RMSE=    √(
 ∑       ̂   
 
   
 
) 
where the root mean squared error (RMSE) is calculated from the difference 
between the actual null allele frequency (pi), the estimated frequency   ̂ ) and the 
visible alleles where k is the number of visible alleles at a locus. 
 
3.3. Results 
3.3.1. Basis of investigation for the presence of a null allele at the HLD97 
locus 
As previously mentioned (section 3.1), observations of successful PCR 
amplification at all loci except the HLD97 locus was noted in 14 samples with 
good quality profiles obtained at the remaining loci, as well as good peak 
morphology and high relative fluorescent units. Based on these observations it 
was hypothesized that the possible presence of a null allele, was responsible for 
the failure of PCR amplification at the HLD97 locus. 
 
3.3.2. Investigating the primer binding properties of the Investigator DIPplex 
HLD97 primers (Qiagen) 
Figure 3.2 shows an electropherogram of a sample with PCR amplification at all 
loci including the HLD97 locus using the manufacturer‘s recommended annealing 
temperature of 61 
o
C, in a final volume of 10 uL using 40 % of manufacturer‘s  
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Figure 3.2 An electropherogram of a DNA profile with PCR amplification at all of the 30 loci as well as the HLD97 locus using 
manufacturer‘s recommended annealing temperature of 61 oC using 10 uL.(Qiagen, 2011).  
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conditions (Qiagen, 2011). Figure 3.3 shows an electropherogram of the red 
fluorescent dye labelled alleles of a sample containing a HLD97 null allele 
amplified using the manufacturer‘s recommended annealing temperature of 61 oC. 
The absence of both HLD97 alleles is clearly visible. The annealing temperature 
as per manufacturer‘s recommendation was decreased by 5 oC to lower the 
stringency of the primer binding to the target sequence. Successful PCR multiplex 
amplification of both alleles at the HLD97 locus was obtained at a lower 
annealing temperature of 56 
o
C in four samples in which no amplification was 
obtained for HLD97 using manufacturer‘s PCR annealing temperature. Figure 3.4 
shows an electropherogram of the same sample amplified using an annealing 
temperature of 56 
o
C. The presence of the HLD97 insertion allele is visible. This 
confirms that the HLD97 primer binding ability is affected. The most likely 
explanation is the presence of a mutation in the primer binding site. 
 
3.3.3. Primer optimisation and PCR amplification 
The optimal primer annealing temperature for the designed primer pair as 
determined using the Oligo 1.4 primer analysis software (Rychlik, 2007) was  
62
 o
C. Successful PCR amplification was observed for the temperature range 58 
o
C to 65.8 
o
C (Figure 3.5). The best PCR amplification was observed for 
annealing temperatures ranging between 60.1 
o
C and 64.6 
o
C as indicated by the 
strong intensity of the PCR bands. The amplified PCR product size was within the 
expected size range (450-500 bp) as indicated by the ladder used. No 
contamination was present as indicated by the absence of amplification in the 
negative control (not shown). 
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Figure 3.3 An electropherogram showing the red fluorescent dye labels of a HLD97 null allele amplified with Tm of 61 
o
C. Black 
arrows indicate the absence of the HLD97 insertion and deletion alleles. The loci names are indicated. ( +) indicates insertion allele; (-) 
indicates deletion allele. 
D97-
DELETION 
ALLELE 
D97+ 
INSERTION 
ALLELE 
D136+ D133- D133+ D39+ D128+ D84- D40+ D136- D40- D128- 
D84+ D39- 
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Figure 3.4 An electropherogram showing the red fluorescent dye labels of a HLD97 null allele amplified with Tm of 56
 o
C. The presence 
of the HLD97 insertion allele is highlighted in red. The loci names are indicated. ( +) indicates insertion allele; (-) indicates deletion allele 
D97-
DELETION 
ALLELE 
D97+ 
INSERTION 
ALLELE 
D136+ D133- D133+ D39+ D128+ D84- D40+ D136- D40- D128- 
D84+ D39- 
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Figure 3.5 Gradiënt PCR of sample 2 
L = Hyper Ladder V; Lane 1, 58
 o
C; Lane 2, 58.2
 o
C; Lane 3, 58.6
 o
C; Lane 4, 59.2 
o
C; Lane 5, 
 60.1
 o
C; Lane 6, 61.2
 o
C; Lane 7, 62.6 
o
C; Lane 8, 63.8
 o
C; Lane 9, 64.6 
o
C; Lane 10, 65.4
 o
C; 
Lane 11, 65.8
 o
C; Lane 12, 66
 o
C 
 
3.3.4. DNA sequencing analysis 
3.3.4.1. DNA sequencing 
As mentioned in section 3.2.8.1, Sanger DNA sequencing was performed to 
determine the nucleotide sequences of the selected samples‘ genotypes and to 
investigate the possible presence of nucleotide variations. DNA sequencing 
confirmed the genotypes of the insertion homozygote- (Figure 3.6), deletion 
homozygote-(Figure 3.7) and heterozygote- individuals (Figure 3.8). The positive 
control as provided by the kit is a heterozygote for the HLD97 locus and was also 
sequenced. The DNA sequence of the heterozygote positive control reflects this 
by the presence of a mixed DNA sequence trace starting at the indel insertion site 
which is caused by the presence of both alleles (Figure 3.8).  
3.3.4.1.1. HLD97 null allele sequencing results 
Figure 3.9 shows the chromatogram of a HLD97 homozygote null allele 
individual sequenced using the forward primer. The 14 bp insertion sequence is 
present. Sequencing of the homozygote HLD97 null allele samples therefore 
confirmed that the true genotype of the HLD97 null allele homozygote samples is 
that of an insertion homozygote. 
L 1 2 3 4 5 6 7 8 9 10 11 12 
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Figure 3.6. A chromatogram of a HLD97 insertion allele homozygote individual. The insertion site and insertion sequence (shaded) are 
indicated. The wild type G-nucleotide is indicated in red.  
14 BP SEQUENCE INSERTION SITE 
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Figure 3.7 A chromatogram of an HLD97 deletion homozygote individual. The insertion site is indicated. The wild type G-nucleotide is 
indicated in red. 
INSERTION SITE 
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Figure 3.8 A chromatogram of an HLD97 heterozygote individual. The visible mixed trace and decrease in trace quality from the 
insertion site (indicated) onwards is visible and shaded. It is caused by the presence of both the insertion and deletion alleles. 
INSERTION SITE 
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Figure 3.9 A sequence chromatogram using the reverse primer of an HLD97 null allele individual. The presence of the 14 bp insertion 
sequence is indicated and shaded, confirming the true genotype to be insertion homozygote. The mutant A nucleotide is indicated in red.  
14 BP SEQUENCE 
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3.3.4.2. Sequence alignments 
Consensus sequences were constructed as mentioned in section 3.2.8.3. 
Comparison between the consensus sequences and the Genbank reference 
sequence is shown in Figure 3.10. 
 
3.3.4.2.1. HLD97 null allele sequence alignments 
The sequence alignments constructed using the HLD97 null allele sequences is 
shown in Figure 3.11. It confirms the actual genotype of HLD97 null allele 
homozygote samples as being insertion homozygote as stated in section 3.3.4.1.1. 
In all of the sequenced HLD97 null allele homozygote samples, the sequencing 
results revealed the presence of a G to A substitution located 75 bp downstream 
from the HLD97 indel site (Figure 3.11 and Figure 3.12). This mutation would 
explain the lack of PCR amplification at the HLD97 locus, as it is likely located 
within the primer binding site. This is also supported by successful PCR 
amplification obtained at a lower annealing temperature that caused a decrease 
One individual genotyped as a HLD97 deletion homozygote revealed a 
heterozygote genotype after sequencing. This result is explained in the next 
section 3.3.4.2.1 (Figure 3.13). 
 
3.3.5. Statistical and analytical estimation of null allele frequencies 
The null allele estimators by Chakraborty et al and Brookfield are based on the 
assumption of homozygote excess due to null allele presence in the population but 
are not reliable due to these estimators not accounting for the presence of missing 
data. These estimators are calculated based on allele frequencies (Brookfield 
estimators) and observed and expected heterozygosity values (Chakraborty et al‘s 
estimator). 
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Ref_Sequence_(rs17238892)    AGGCGGAGGT TGCGGTGAAC CAAGATAGCA CCATTGCACT CCAGCCTGGG CAACAAGAGT GAAACTCCGT CTCAAAAAGA 
Cons_Insertion_(K009)        .......... .......... .......... .......... .......... .......... .......... .......... 
Cons_Deletion_(X_11_076)     .......... .......... .......... .......... .......... .......... .......... .......... 
Cons_Null_Allele_(ZU_11_68)  .......... .......... .......... .......... .......... .......... .......... .......... 
 
Ref_Sequence_(rs17238892)    G--------- -----TTCAC AGTTTCTCTT TTGCTTTGAT TTTCTTATCT GCCGGATAAC AATAGTATTT TGGAAGGCAG 
Cons_Insertion_(K009)        .AGAGAAAGC TGAAG..... .......... .......... .......... .......... .......... .......... 
Cons_Deletion_(X_11_076)     .--------- -----..... .......... .......... .......... .......... .......... .......... 
Cons_Null_Allele_(ZU_11_68)  .AGAGAAAGC TGAAG..... .......... .......... .......... .......... .......... .....A.... 
 
Figure 3.10 The sequence alignments performed with consensus sequences representing homozygote individuals for the insertion 
(K009), deletion (X_11_76) and null allele (ZU_11_68). The 14 bp insertion sequence is indicated in green. The wild type G 
nucleotide present in the GenBank reference sequence is substituted with an A nucleotide in the null allele consensus sequence 
(ZU_11_68) as indicated in red. Cons=Consensus 
 
 
 
 
 64 
 
 
 
  
Genbank Ref (rs17238892) AAATTAGCTG GGCGTGGTGG TGCATGCCTG TAATGCCAGC TACTCGGGAG GCTGAGGCAG GAGAATCACT TAAACCTGGG 
Consensus_X_11_101       .......... .......... .......... .......... .......... .......... .......... .......... 
Consensus_X_11_160       .......... .......... .......... .......... .......... .......... .......... .......... 
Consensus_ZU_11_68       .......... .......... .......... .......... .......... .......... .......... .......... 
 
Genbank_Ref_(rs17238892) AGGCGGAGGT TGCGGTGAAC CAAGATAGCA CCATTGCACT CCAGCCTGGG CAACAAGAGT GAAACTCCGT CTCAAAAAGA 
Consensus_X_11_101       .......... .......... .......... .......... .......... .......... .......... .......... 
Consensus_X_11_160       .......... .......... .......... .......... .......... .......... .......... .......... 
Consensus_ZU_11_68       .......... .......... .......... .......... .......... .......... .......... .......... 
 
Genbank_Ref_(rs17238892) G--------- -----TTCAC AGTTTCTCTT TTGCTTTGAT TTTCTTATCT GCCGGATAAC AATAGTATTT TGGAAGGCAG 
Consensus_X_11_101       .AGAGAAAGC TGAAG..... .........- .......... .......... .-........ .......... .....A.... 
Consensus_X_11_160       .AGAGAAAGC TGAAG..... .......... .......... .......... .......... .......... .....A.... 
Consensus_ZU_11_68       .AGAGAAAGC TGAAG..... .......... .......... .......... .......... .......... .....A.... 
Figure 3.11 Sequence alignments using three of the HLD97 null allele samples with the 14 bp insertion sequence indicated in 
green. The wild type G nucleotide in the Genbank reference sequence is substituted with an A nucleotide in the null allele samples 
as indicated in red. 
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Figure 3.12. Chromatograms indicating the presence of the wild type G nucleotide (A) and the mutant A nucleotide resulting in the HLD97 
null allele (B). 
HLD97 INSERTION 
HOMOZYGOTE 
HLD97 NULL ALLELE 
HOMOZYGOTE 
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The fourth null allele frequency estimator used is the ML-NullFreq software 
program (Kalinowski and Taper, 2006) and is likely the most reliable estimator 
for this particular case. This estimator is based on actual genotype counts and 
calculates null allele frequencies whether missing data is present or not. 
The estimated null allele frequencies are listed in Table 3.2 (A), (B), (C), (D) and 
(E). Null allele frequencies were calculated using the four different methods for 
comparison purposes. The presence of a null allele at the HLD97 locus has been 
demonstrated in the Xhosa and Zulu populations. The allele frequencies for 
HLD97 calculated using all four estimators listed in Table 3.3. in the primer 
binding stringency as described in section 3.3.2.Furthermore, the contradicting 
results obtained for genotyping (insertion homozygote) and direct sequencing 
(heterozygote) of one individual as described in section 3.3.4.1 is also explained 
by the presence of a mutation in the primer binding site (Figure 3.13). As a 
heterozygote individual possesses the insertion as well as the deletion allele, a 
mutation in one of the two alleles can result in PCR amplification of one allele 
only. In the case of this heterozygote sample, the insertion allele possesses the 
mutation, similar to the samples containing the HLD97 null allele. This results in 
only the deletion allele being detected. 
Using the Brookfield estimator 2, allele frequencies at the HLD97 locus in these 
two populations were higher than 60 % (0.449 ≥ 0.620). Using the ML-NullFreq 
program, allele frequencies were between 26 % and 33 % (0.261 ≥ 0.327). This is 
expected considering that individuals with no observed amplification at the 
HLD97 locus were observed in the Xhosa and Zulu populations. In both the 
Indian and Coloured populations the calculated null allele frequencies were high 
(0.118 ≥ 0.334) with the Indian population HLD97 null allele frequency well 
above 30 %, providing strong evidence for the possible presence of a null allele at 
this locus as opposed to the Afrikaner population which had null allele 
frequencies at the HLD97 locus just below 15 % (0.061 ≥ 0.147). 
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Figure 3.13 (A) An electropherogram of an HLD97 deletion homozygous individual as genotyped. (B) The true genotype is confirmed to be an 
HLD97 heterozygote by direct sequencing. The visible mixed trace and decrease in trace quality starting from the insertion site (indicated) is visible. 
D97-
DELETION 
ALLELE D97+ INSERTION 
ALLELE 
(ABSENT) 
D136+ D133- D133+ D39+ D128+ D84- D40+ D136- D40- D128- 
D84+ D39- 
B 
A 
INSERTION SITE 
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Table 3.2 (A) Null allele frequency estimates of the 30 indel loci for the 
Afrikaner population calculated using four methods: Charkraborty null allele 
estimator 
a
, Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software 
program 
c
. 
 
Afrikaner 
  Null Allele Estimator 
Locus Charkraborty Brookfield 1 Brookfield 2 ML- 
NullFreq 
HLD77 0.007 0.005 0.012 0.003 
HLD45 -0.006 -0.004 -0.002 0.000 
HLD131 -0.042 -0.029 -0.018 0.000 
HLD70 0.048 0.031 0.072 0.029 
HLD6 0.024 0.016 0.037 0.014 
HLD111 -0.052 -0.036 -0.023 0.000 
HLD58 -0.050 -0.035 -0.022 0.000 
HLD56 0.045 0.027 0.062 0.027 
HLD118 0.017 0.011 0.026 0.009 
HLD92 -0.003 -0.002 -0.001 0.000 
HLD93 -0.031 -0.022 -0.014 0.000 
HLD99 -0.031 -0.021 -0.014 0.000 
HLD88 0.016 0.010 0.025 0.009 
HLD101 -0.042 -0.029 -0.019 0.000 
HLD67 -0.022 -0.015 -0.009 0.000 
HLD83 -0.067 -0.048 -0.030 0.000 
HLD114 -0.022 -0.015 -0.009 0.000 
HLD48 0.060 0.037 0.088 0.036 
HLD124 -0.031 -0.021 -0.013 0.000 
HLD122 -0.045 -0.031 -0.020 0.000 
HLD125 0.017 0.011 0.026 0.009 
HLD64 0.009 0.006 0.014 0.005 
HLD81 0.016 0.010 0.025 0.009 
HLD136 0.017 0.011 0.026 0.009 
HLD133 -0.095 -0.069 -0.043 0.000 
HLD97 0.103 0.062 0.147 0.061 
HLD40 -0.059 -0.042 -0.027 0.000 
HLD128 0.017 0.011 0.026 0.009 
HLD39 0.001 0.001 0.002 0.000 
HLD84 0.031 0.020 0.047 0.019 
HLD97 locus frequencies with known presence of null allele highlighted in bold 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006)  
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Table 3.2 (B) Null allele frequency estimates of the 30 indel loci for the Mixed 
Ancestry population calculated using three methods: Charkraborty null allele 
estimator 
a
, Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software 
program 
c
. 
 
Mixed Ancestry 
  Null Allele Estimator 
Locus Charkraborty Brookfield 1 Brookfield 2 ML- 
NullFreq 
HLD77 -0.044 -0.030 0.000 0.000 
HLD45 -0.018 -0.012 0.000 0.000 
HLD131 -0.029 -0.020 0.000 0.000 
HLD70 -0.016 -0.009 0.000 0.000 
HLD6 0.048 0.029 0.039 0.029 
HLD111 -0.025 -0.016 0.000 0.000 
HLD58 -0.028 -0.018 0.000 0.000 
HLD56 0.086 0.051 0.052 0.051 
HLD118 -0.041 -0.029 0.000 0.000 
HLD92 0.027 0.017 0.023 0.016 
HLD93 0.058 0.036 0.034 0.035 
HLD99 0.053 0.030 0.007 0.032 
HLD88 0.002 0.002 0.000 0.000 
HLD101 0.014 0.009 0.000 0.008 
HLD67 0.059 0.035 0.025 0.036 
HLD83 0.002 0.002 0.018 0.000 
HLD114 -0.009 -0.006 0.006 0.000 
HLD48 -0.005 -0.003 0.024 0.000 
HLD124 0.028 0.018 0.013 0.017 
HLD122 -0.007 -0.004 0.000 0.000 
HLD125 -0.007 -0.004 0.013 0.000 
HLD64 -0.016 -0.008 0.023 0.000 
HLD81 0.101 0.059 0.082 0.059 
HLD136 -0.001 0.000 0.029 0.000 
HLD133 0.053 0.031 0.025 0.032 
HLD97 0.256 0.134 0.118 0.134 
HLD40 -0.069 -0.045 0.000 0.000 
HLD128 0.010 0.007 0.015 0.005 
HLD39 -0.015 -0.010 0.000 0.000 
HLD84 -0.021 -0.013 0.003 0.000 
HLD97 locus frequencies with known presence of null allele highlighted in bold 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006)  
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Table 3.2 (C) Null allele frequency estimates of the 30 indel loci for the Indian-
Asian population calculated using three methods: Charkraborty null allele 
estimator 
a
, Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software 
program 
c
. 
 
Indian-Asian 
  Null Allele Estimator 
Locus Charkraborty Brookfield 1 Brookfield 2 ML- 
NullFreq 
HLD77 -0.024 -0.013 -0.007 0.000 
LD45 -0.019 -0.012 -0.007 0.000 
HLD131 0.000 0.000 0.000 0.000 
HLD70 0.010 0.006 0.013 0.005 
HLD6 -0.038 -0.026 -0.017 0.000 
HLD111 -0.029 -0.018 -0.011 0.000 
HLD58 -0.068 -0.044 -0.026 0.000 
HLD56 -0.007 -0.004 -0.002 0.000 
HLD118 -0.054 -0.038 -0.024 0.000 
HLD92 0.035 0.022 0.053 0.021 
HLD93 0.030 0.019 0.045 0.018 
HLD99 -0.024 -0.016 -0.010 0.000 
HLD88 0.066 0.040 0.092 0.039 
HLD101 0.043 0.027 0.065 0.026 
HLD67 -0.008 -0.005 -0.003 0.000 
HLD83 0.041 0.024 0.055 0.025 
HLD114 -0.003 -0.002 -0.001 0.000 
HLD48 -0.026 -0.018 -0.011 0.000 
HLD124 -0.034 -0.023 -0.015 0.000 
HLD122 -0.012 -0.008 -0.005 0.000 
HLD125 -0.049 -0.034 -0.022 0.000 
HLD64 -0.040 -0.019 -0.010 0.000 
HLD81 0.048 0.029 0.068 0.029 
HLD136 0.002 0.001 0.003 0.000 
HLD133 0.051 0.031 0.072 0.031 
HLD97 0.327 0.147 0.334 0.155 
HLD40 0.044 0.024 0.053 0.026 
HLD128 -0.046 -0.032 -0.020 0.000 
HLD39 -0.007 -0.005 -0.003 0.000 
HLD84 0.023 0.014 0.031 0.014 
HLD97 locus frequencies with known presence of null allele highlighted in bold 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006)  
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Table 3.2 (D) Null allele frequency estimates of the 30 indel loci for the Xhosa 
population calculated using three methods: Charkraborty null allele estimator 
a
, 
Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software program 
c
. 
 
Xhosa 
  Null Allele Estimator 
Locus Charkraborty Brookfield 1 Brookfield 2 ML- 
NullFreq 
HLD77 0.017 0.010 0.021 0.010 
HLD45 -0.034 -0.022 -0.014 0.000 
HLD131 0.057 0.032 0.071 0.034 
HLD70 -0.036 -0.009 -0.003 0.000 
HLD6 0.017 0.010 0.024 0.010 
HLD111 0.013 0.008 0.020 0.007 
HLD58 -0.030 -0.012 -0.005 0.000 
HLD56 0.074 0.045 0.106 0.044 
HLD118 0.009 0.006 0.013 0.004 
HLD92 0.022 0.014 0.032 0.013 
HLD93 -0.070 -0.051 -0.032 0.000 
HLD99 0.021 0.012 0.027 0.012 
HLD88 -0.042 -0.026 -0.015 0.000 
HLD101 0.057 0.020 0.041 0.032 
HLD67 0.009 0.005 0.013 0.004 
HLD83 -0.012 -0.008 -0.005 0.000 
HLD114 0.038 0.016 0.034 0.022 
HLD48 -0.054 -0.033 -0.018 0.000 
HLD124 -0.036 -0.018 -0.009 0.000 
HLD122 0.007 0.004 0.010 0.003 
HLD125 0.107 0.036 0.073 0.055 
HLD64 0.018 0.008 0.017 0.010 
HLD81 0.020 0.013 0.031 0.012 
HLD136 -0.037 -0.022 -0.013 0.000 
HLD133 0.012 0.008 0.018 0.007 
HLD97 0.398 0.190 0.449 0.261 
HLD40 0.026 0.014 0.030 0.015 
HLD128 -0.108 -0.079 -0.049 0.000 
HLD39 0.020 0.013 0.030 0.012 
HLD84 -0.008 -0.004 -0.002 0.000 
HLD97 locus frequencies with known presence of null allele highlighted in bold 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006)  
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Table 3.2 (E) Null allele frequency estimates of the 30 indel loci for the Zulu 
populationcalculated using three methods: Charkraborty null allele estimator 
a
, 
Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software program 
c
. 
 
Zulu 
  Null Allele Estimator 
Locus Charkraborty Brookfield Brookfield 
2 
ML- 
NullFreq 
HLD77 -0.017 -0.011 -0.006 0.000 
HLD45 -0.015 -0.009 -0.005 0.000 
HLD131 -0.073 -0.042 -0.023 0.000 
HLD70 -0.041 -0.011 -0.004 0.000 
HLD6 -0.079 -0.049 -0.027 0.000 
HLD111 -0.015 -0.009 -0.005 0.000 
HLD58 -0.025 -0.009 -0.004 0.000 
HLD56 -0.039 -0.027 -0.017 0.000 
HLD118 0.007 0.005 0.011 0.003 
HLD92 0.008 0.005 0.012 0.004 
HLD93 -0.043 -0.030 -0.019 0.000 
HLD99 0.104 0.057 0.129 0.060 
HLD88 -0.031 -0.017 -0.009 0.000 
HLD101 -0.051 -0.017 -0.007 0.000 
HLD67 0.068 0.038 0.086 0.040 
HLD83 0.060 0.036 0.084 0.036 
HLD114 -0.054 -0.018 -0.008 0.000 
HLD48 0.035 0.020 0.046 0.021 
HLD124 0.042 0.016 0.032 0.024 
HLD122 -0.025 -0.016 -0.009 0.000 
HLD125 0.070 0.027 0.055 0.039 
HLD64 -0.030 -0.014 -0.007 0.000 
HLD81 0.073 0.045 0.106 0.044 
HLD136 -0.049 -0.030 -0.018 0.000 
HLD133 0.026 0.016 0.036 0.015 
HLD97 0.560 0.255 0.620 0.327 
HLD40 0.024 0.012 0.025 0.014 
HLD128 0.043 0.025 0.058 0.026 
HLD39 -0.063 -0.042 -0.025 0.000 
HLD84 0.023 0.013 0.029 0.013 
HLD97 locus frequencies with known presence of null allele highlighted in bold 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006)  
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Table 3.3. Null allele frequency estimates of the HLD97 locus for all populations calculated using four methods: Charkraborty null allele 
estimator 
a
, Brookfield null allele estimators
b 
1 and 2 and ML-NullFreq software program 
c
. 
Population 
Null Allele Estimator 
Charkraborty Brookfield 1 Brookfield 2 ML- NullFreq 
Afrikaner 0.103 0.062 0.147 0.061 
Mixed Ancestry 0.256 0.134 0.118 0.134 
Indian-Asian 0.327 0.147 0.334 0.155 
Xhosa 0.398 0.190 0.449 0.261 
Zulu 0.560 0.255 0.620 0.327 
Average 0.329 0.158 0.333 0.188 
a
 Charkraborty (Charkraborty, 1992) 
b
 Brookfield (Brookfield, 1996) 
c 
Kalinowski and Taper (2006) 
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The observed null allele frequencies across all other loci were much lower than 
the frequencies observed at the HLD97 locus suggesting the absence of null 
alleles at these loci. 
The fifth method to estimate null allele frequency is using the Hardy-Weinberg 
equation (1 = p
2
 +2pq +q
2
). By applying this method of null allele estimation the 
null allele frequency at locus HLD97 was calculated as 0.343 and 0.279 in the 
Xhosa and Zulu populations, respectively. 
 
3.4. Summary 
No alleles were observed for HLD97 in six of the 102 individuals from the Xhosa 
population and in eight of the 103 individuals from the Zulu populations, with 
successful PCR amplification detected at all other loci. This observation led to the 
hypothesis that the possible presence of a null allele is responsible for the lack of 
PCR amplification at the HLD97 locus. 
PCR amplification using less stringent conditions of four the null allele 
homozygotes confirmed the true genotype to be that of an insertion homozygote. 
Confirmation of these 4 individual genotypes via sequencing determined the true 
genotype to be homozygote for the HLD97 insertion allele. DNA sequencing 
identified the presence of a G to A substitution in the samples homozygous for the 
HLD97 null allele, located 75 bp downstream from the HLD97 indel site, on 
chromosome 13. The presence of the G to A substitution in the primer binding site 
would affect the primer binding properties, resulting in primer binding failure. 
Similar observations have previously been reported at the HLD97 locus with an 
allele imbalance observed in heterozygotes (Alvarez et al, 2011; Fondevila et al, 
2012; Martin et al, 2012) and a partially silent allele at HLD97 reported by Friis et 
al, 2012. In these cases the presence of a G/A transition 75 bp from the insertion 
site was confirmed through DNA sequencing in all four studies. LaRue et al 
(2012) made the same observation of allele imbalance at HLD97 but did not 
confirm the presence of the G/A transition through sequencing. The peak 
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imbalance was hypothesized to be caused by insufficient primer annealing due to 
the presence of the G/A substitution within the primer binding site.  
The null allele frequency estimators indicated that a high number of individuals 
within the Mixed Ancestry, Indian Asian, Xhosa and Zulu populations may 
contain the HLD97 insertion null allele. Therefore, considering the three possible 
alleles i.e. wild type insertion-, mutant insertion allele (null allele), and wild type 
deletion; six possible genotypes are produced of which only four genotypes are 
visibly observable: 
i) deletion homozygote 
ii) insertion homozygote 
iii) heterozygote 
iv) homozygote null allele 
The mutation is carried on the insertion allele. In a heterozygote individual who 
may possess the mutant insertion allele and the wild type deletion allele, only the 
deletion allele will be amplified. This will result in the heterozygote individual 
falsely being observed as a deletion homozygote and consequently an excess of 
homozygotes. 
Null alleles have direct influences on population and forensic genetics. Their 
presence increases the levels of homozygosity by being falsely genotyped as 
homozygotes and consequently decreases heterozygosity levels. High enough null 
allele frequencies can cause a shift in HWE. In doing so null alleles affect 
population structure estimates by interfering with measurements of genetic 
diversity and decreasing estimates of relatedness (Kalinowski and Taper, 2006). A 
more serious implication of the presence of a null allele is the affect it has on 
possible false exclusions in parentage determination. 
With the possible presence of a null allele in a sample population, solutions 
should be considered to deal with its presence and the effect it might have on 
population data and kinship analysis: 
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1. Redesigning the primers so that the primer binding sites are not located in or 
near the mutation site is a possible option. 
2. Another alternative is to design degenerate primers, taking into consideration 
the mutation site and using these primers in addition to the original primer set. 
This will accommodate individuals that possess the polymorphic site and result in 
successful amplification of all carriers.  
3. A third option is to exclude the locus containing the null allele altogether.  
All three options have considerations to bear in mind. If considering redesigning 
the primers, the effect of the newly designed primers on the multiplex PCR should 
be investigated and optimization of multiplex PCR reaction may need to be 
repeated which might have further consequences on time and labour costs. This 
approach was chosen when a primer binding polymorphism at D7S820 led to 
allele dropout using the Promega Powerplex® 1.1 kit (Promega) (Schumm et al, 
1996). 
This also counts for the option of degenerate primers and the time and costs 
involved needs to be considered in cases where only a few samples containing 
null alleles are present in proportion to the samples not containing the null allele. 
Discrepancies in results for the D16S539 locus were detected in data generated by 
two independent laboratories, using the Promega Powerplex® 1.1 (Promega) 
(Nelson et al, 2002). Upon further investigation a T/A mutation located within the 
primer binding site was found to be the cause of the null allele presence. As a 
solution to the problem of the D16S539 null allele, a degenerate primer was 
designed and included in the Promega Powerplex® 1.1 kit (Promega).  
The option to exclude the locus is a viable option when primer binding problems 
are detected early in development. This option was chosen in the early stages of 
development of the Forensic Science Service‘s second generation multiplex when 
the D19S253 locus was excluded (Urquhart et al, 1995). 
For application in South Africa, I would suggest excluding the locus containing 
the null allele from kinship analysis. This will be the most affordable option as 
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well as being less time consuming and labour intensive, considering the other 
options relating to primer design. 
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Chapter 4 
Statistical Analysis on population data from five South African populations 
 
4.1. Introduction 
Statistics is the science of uncertainty and its measurement and it is used to 
provide a sense of how reliable a measurement is if made multiple times (Butler, 
2005). In forensics, statistical analyses of DNA profiles are mainly performed to 
establish the occurrence of a DNA profile within a population. This is performed 
by estimating certain forensic parameters. These include match probability, power 
of exclusion and discrimination power. All of these are estimates that give an 
indication of how rare a profile is within a certain population.  
Statistical analyses can also reveal information about the population‘s genetic 
diversity and history. In addition to the information obtainable on the population 
using statistics, information can also be obtained on the actual forensic kit used to 
generate the genetic information eg. the quality of the markers chosen. These 
forensic parameters can be used to determine a forensic kit‘s ability to be used as 
a forensic tool.  
This chapter looks at statistical analyses performed on the population data and its 
application in forensics in the South African population.  
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4.2 Materials and methods 
4.2.1 Samples 
DNA was extracted from blood and buccal swabs from Afrikaner (N = 101), 
Mixed Ancestry (N = 104), Indian-Asian (N = 102), Xhosa (N = 102) and Zulu  
(N = 103) populations are included in the following analysis. For more details see 
chapter 2, section 2.2.2). 
 
4.2.2 Estimation of population and forensic parameters 
To assess the Investigator kit‘s efficiency for application in individual 
identification, certain forensic parameters are estimated. The forensic parameters 
match probability (MP), power of discrimination (DP), polymorphism information 
content (PIC), power of exclusion (PE) and typical paternity index (TPI) were 
estimated using PowerStats (Tereba, 1999). Allele frequencies, expected and 
observed heterozygosity, as well as probability values (p-values) for Hardy-
Weinberg equilibrium were estimated using Arlequin (Excoffier et al, 2005). 
 
4.2.3. Population Comparisons 
4.2.3.1. Factorial Correspondence Analysis (FCA) 
The genetic relationship between the five populations was investigated through 
Factorial Correspondence Analysis (FCA). FCA is a multivariate statistical 
method that is used to extract information from contingency tables i.e. allele 
frequency tables. The aim of FCA is to build modalities of variables to determine 
if any correlations exist and allows graphical summaries of large datasets. Scatter 
plots of individuals and populations were constructed through FCA using the 
computer program Genetix v.4.05.2. (Belkhir et al, 2002). 
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4.2.3.2. FST-analysis 
FST- analysis is a parameter for estimating genetic differentiation amongst 
populations. A large -value (closer to 1) is indicative of more differentiation 
whereas a small -value (closer to 0) indicates less differentiation amongst 
populations. The amount of genetic differentiation is related to evolutionary 
processes that populations experience i.e. genetic drift, migration and mutation. 
FST- analysis was estimated using Arlequin (Excoffier et al, 2005) with genetic 
distance being estimated using Slatkin‘s method (Slatkin, 1995) with 1000 
permutations applied for estimation of significance. 
 
4.2.3.3. Phylogenetic tree construction 
Phylogenetic tree construction is a way to investigate genetic differences amongst 
populations. A phylogenetic tree is constructed using genetic distance where the 
genetic distance calculated between populations is equivalent to the tree branch 
distance between populations on the phylogenetic tree (Kalinowski, (2009). 
Genetic similaries between populations are indicated by short branch lengths; the 
shorter the branches the higher the genetic similaries. 
Phylogenetic tree construction was conducted using the program Treefit 
(Kalinowski, 2009) and visualised using TreeView (Page, 1996). The progam 
TreeFit allows for calculation of the degree of fit between observed data and 
phylogenetic tree construction using R
2
 statistics; the closer the R
2
-value is to 1.0, 
the better the tree summarises the genetic relationships between the populations 
(Kalinowski, (2009).  
Using the program Treefit (Kalinowski, 2009), the Neighbour-Joining (NJ) 
method was used to estimate genetic distance using Weir and Cockerham‘s 
method (1984) for the phylogenetic tree construction. This method of FST-analysis 
is used to estimate population differentiation where the -value ranges from 0 to 1 
with a value of 0 indicating random mating or panmixis and a value of 1 
indicating total population isolation with no genetic diversity between 
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populations. The NJ method does not assume equal evolutionary rates between 
populations. 
 
4.3. Results 
4.3.1 Estimation of population and forensic parameters 
4.3.1.1 Heterozygosity and Hardy-Weinberg Equilibrium 
Table 4.1 (A), (B), (C), (D) and (E) summarizes the calculated values for allele 
frequency and observed and expected heterozygosity for all five populations. The 
mean observed heterozygosity values for the Afrikaner, Mixed Ancestry, Indian-
Asian, Xhosa and Zulu populations were 0.501, 0.454, 0.452, 0.396 and 0.376, 
respectively. In all but Afrikaner population, observed heterozygosity values at 
the HLD97 locus were considerably lower compared to the expected 
heterozygosity values. 
The probability values (p-values) for Hardy-Weinberg equilibrium are listed in 
Table 4.1 (A), (B), (C), (D) and (E) for each locus in the five populations. For the 
Afrikaner population, all loci were in Hardy-Weinberg equilibrium (p > 0.05) 
except HLD133 (p < 0.041). For the other four populations deviation from Hardy-
Weinberg equilibrium was detected in the Xhosa population at locus HLD128  
(p < 0.023) as well as at locus HLD97 in all populations except the Afrikaner 
population. After Bonferroni correction the significance level changes from 0.05 
to 0.00167 to account for multiple testing (Bland and Altman, 1995). After 
Bonferroni correction, all p-values were greater than 0.00167 and all loci 
including HLD28 were therefore in Hardy-Weinberg equilibrium (HWE) except 
the HLD97 locus in the Mixed Ancestry, Indian Asian, Xhosa and Zulu 
population 
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4.3.1.2 Forensic parameters 
Table 4.2 (A), (B), (C), (D) and (E) lists the estimated values for power of 
discrimination, match probability, power of exclusion and typical paternity index 
per locus, for each of the five populations. Polymorphic information content (PIC) 
is a measure of the polymorphic level of a locus (Goodwin et al, 2011). It was 
determined that a diallelic locus can have a maximum PIC value of 0.375 
(Hildebrand et al, 1992). The mean PIC values of each of the five populations are 
listed in Table 4.2 (A), (B), (C), (D) and (E). Again, the highest PIC value (mean 
= 0.37) was observed in the Afrikaner population for loci HLD77, HLD92, 
HLD93, HLD99, HLD83, HLD125, HLD136, HLD40 and HLD128. This value is 
quite high and therefore the loci are considered as informative. For the remaining 
populations the mean PIC value was in the range of 0.308 - 0.355. 
The combined indices (combined power of discrimination, combined match 
probability and combined power of exclusion) for all five populations are 
summarized in Table 4.3. The highest values for all three indices were calculated 
for the Afrikaner population. The highest combined power of discrimination 
(CDP) as calculated for the Afrikaner population was 0.9999999999996. This 
value can be interpreted as 99.99999999996% of the Afrikaner population can be 
excluded as donors of a chosen DNA profile. In the Afrikaner population the 
Combined Power of Exclusion (CPE) was calculated as 0.9983 with the lowest 
CPE observed for the Zulu population at 0.9783. For the remaining three 
populations the CPE was 0.9938, 0.9944 and 0.9838 for the Mixed Ancestry, 
Indian-Asian and Xhosa populations, respectively. The combined match 
probability values as listed in Table 4.3 was calculated as 4.25 X 10
-13
 for the 
Afrikaner and 3.55 X10
-11
 for the Xhosa population. 
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Table 4.1 (A) Allele frequencies and heterozygosity estimates for the the 30 
Indels for the Qiagen Investigator Kit in the Afrikaner population. 
  Afrikaner 
(N=101 ) 
  
Locus 
Deletion 
Allele  
Frequency 
Observed 
Heterozygosity 
(He) 
 Expected 
Heterozygosity 
(Ho) 
P-Value 
(HWE) 
HLD77 0.505 0.495 0.502 1.000 
HLD45 0.460 0.505 0.499 1.000 
HLD131 0.426 0.535 0.491 0.417 
HLD70 0.475 0.455 0.501 0.426 
HLD6 0.545 0.475 0.499 0.691 
HLD111 0.465 0.554 0.500 0.320 
HLD58 0.475 0.554 0.501 0.321 
HLD56 0.347 0.416 0.455 0.389 
HLD118 0.574 0.475 0.491 0.839 
HLD92 0.520 0.505 0.502 1.000 
HLD93 0.485 0.535 0.502 0.555 
HLD99 0.505 0.535 0.502 0.556 
HLD88 0.530 0.485 0.501 0.843 
HLD101 0.470 0.545 0.501 0.427 
HLD67 0.361 0.485 0.464 0.672 
HLD83 0.495 0.574 0.502 0.167 
HLD114 0.639 0.485 0.464 0.672 
HLD48 0.426 0.436 0.491 0.308 
HLD124 0.381 0.505 0.474 0.533 
HLD122 0.550 0.545 0.498 0.421 
HLD125 0.520 0.485 0.502 0.842 
HLD64 0.381 0.465 0.474 1.000 
HLD81 0.530 0.485 0.501 0.842 
HLD136 0.520 0.485 0.502 0.842 
HLD133 0.426 0.594 0.491 0.041* 
HLD97 0.460 0.406 0.499 0.072 
HLD40 0.520 0.564 0.502 0.233 
HLD128 0.480 0.485 0.502 0.842 
HLD39 0.589 0.485 0.487 1.000 
HLD84 0.441 0.465 0.495 0.549 
Mean   0.501 0.493 
 s.d.   0.045 0.013   
* p < 0.00167; HWE = Hardy Weinberg Equilibrium 
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Table 4.1 (B) Allele frequencies and heterozygosity estimates for the the 30 
Indels for the Qiagen Investigator Kit in the Mixed Ancestry population. 
 Mixed Ancestry 
(N= 104) 
  
Locus 
Deletion 
Allele  
Frequency 
Observed 
Heterozygosity 
(He) 
 Expected 
Heterozygosity 
(Ho) 
P-Value 
(HWE) 
HLD77 0.615 0.519 0.476 0.406 
HLD45 0.572 0.510 0.492 0.840 
HLD131 0.457 0.529 0.499 0.558 
HLD70 0.255 0.394 0.382 0.802 
HLD6 0.635 0.423 0.466 0.402 
HLD111 0.615 0.500 0.476 0.680 
HLD58 0.654 0.481 0.455 0.666 
HLD56 0.370 0.394 0.469 0.139 
HLD118 0.558 0.538 0.496 0.427 
HLD92 0.587 0.462 0.487 0.687 
HLD93 0.409 0.433 0.486 0.311 
HLD99 0.308 0.385 0.428 0.357 
HLD88 0.380 0.471 0.473 1.000 
HLD101 0.317 0.423 0.435 0.822 
HLD67 0.346 0.404 0.455 0.284 
HLD83 0.620 0.471 0.473 1.000 
HLD114 0.399 0.490 0.482 1.000 
HLD48 0.409 0.490 0.486 1.000 
HLD124 0.543 0.471 0.499 0.693 
HLD122 0.668 0.452 0.446 1.000 
HLD125 0.567 0.500 0.493 1.000 
HLD64 0.212 0.346 0.335 1.000 
HLD81 0.375 0.385 0.471 0.093 
HLD136 0.462 0.500 0.499 1.000 
HLD133 0.663 0.404 0.449 0.378 
HLD97 0.587 0.288 0.487 0.000* 
HLD40 0.683 0.500 0.435 0.172 
HLD128 0.466 0.490 0.500 0.847 
HLD39 0.563 0.510 0.495 0.842 
HLD84 0.327 0.462 0.442 0.823 
Mean   0.454 0.466 
 s.d.   0.059 0.037 
 * p < 0.00167; HWE = Hardy Weinberg Equilibrium 
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Table 4.1 (C) Allele frequencies and heterozygosity estimates for the the 30 
Indels for the Qiagen Investigator Kit in the Indian-Asian population. 
 Indian-Asian 
(N=102 ) 
  
Locus 
Deletion 
Allele  
Frequency 
Observed 
Heterozygosity 
(He) 
 Expected 
Heterozygosity 
(Ho) 
P-Value 
(HWE) 
HLD77 0.779 0.363 0.346 0.775 
HLD45 0.328 0.461 0.443 0.823 
HLD131 0.578 0.490 0.490 1.000 
HLD70 0.275 0.392 0.400 0.809 
HLD6 0.534 0.539 0.500 0.549 
HLD111 0.696 0.451 0.425 0.641 
HLD58 0.681 0.500 0.436 0.174 
HLD56 0.206 0.333 0.329 1.000 
HLD118 0.485 0.559 0.502 0.320 
HLD92 0.436 0.461 0.494 0.549 
HLD93 0.539 0.471 0.499 0.690 
HLD99 0.387 0.500 0.477 0.679 
HLD88 0.373 0.412 0.470 0.288 
HLD101 0.515 0.461 0.502 0.433 
HLD67 0.520 0.510 0.502 1.000 
HLD83 0.681 0.402 0.436 0.493 
HLD114 0.588 0.490 0.487 1.000 
HLD48 0.500 0.529 0.502 0.693 
HLD124 0.407 0.520 0.485 0.543 
HLD122 0.662 0.461 0.450 0.829 
HLD125 0.451 0.549 0.498 0.323 
HLD64 0.181 0.324 0.298 0.513 
HLD81 0.382 0.431 0.475 0.402 
HLD136 0.485 0.500 0.502 1.000 
HLD133 0.632 0.422 0.467 0.394 
HLD97 0.696 0.216 0.425 0.000* 
HLD40 0.730 0.363 0.396 0.451 
HLD128 0.529 0.549 0.501 0.428 
HLD39 0.510 0.510 0.502 1.000 
HLD84 0.299 0.402 0.421 0.643 
Mean   0.452 0.455 
 s.d.   0.079 0.056 
 * p < 0.00167; HWE = Hardy Weinberg Equilibrium 
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Table 4.1 (D) Allele frequencies and heterozygosity estimates for the the 30 
Indels for the Qiagen Investigator Kit in the Xhosa population. 
 Xhosa 
(N= 102) 
  
Locus 
Deletion 
Allele  
Frequency 
Observed 
Heterozygosity 
(He) 
 Expected 
Heterozygosity 
(Ho) 
P-Value 
(HWE) 
HLD77 0.730 0.382 0.396 0.802 
HLD45 0.632 0.500 0.467 0.528 
HLD131 0.294 0.373 0.417 0.340 
HLD70 0.074 0.147 0.137 1.000 
HLD6 0.681 0.422 0.436 0.820 
HLD111 0.598 0.471 0.483 0.839 
HLD58 0.868 0.245 0.231 1.000 
HLD56 0.417 0.422 0.489 0.220 
HLD118 0.608 0.471 0.479 1.000 
HLD92 0.603 0.461 0.481 0.683 
HLD93 0.495 0.578 0.502 0.164 
HLD99 0.284 0.392 0.409 0.807 
HLD88 0.314 0.471 0.433 0.490 
HLD101 0.132 0.206 0.231 0.374 
HLD67 0.353 0.451 0.459 1.000 
HLD83 0.417 0.500 0.489 0.840 
HLD114 0.172 0.265 0.286 0.486 
HLD48 0.270 0.441 0.396 0.316 
HLD124 0.794 0.353 0.329 0.553 
HLD122 0.632 0.461 0.467 1.000 
HLD125 0.868 0.186 0.231 0.069 
HLD64 0.186 0.294 0.305 0.745 
HLD81 0.466 0.480 0.500 0.695 
HLD136 0.275 0.431 0.400 0.467 
HLD133 0.623 0.461 0.472 0.835 
HLD97 0.637 0.216 0.501 0.000* 
HLD40 0.755 0.353 0.372 0.599 
HLD128 0.397 0.598 0.481 0.023* 
HLD39 0.373 0.451 0.470 0.832 
HLD84 0.270 0.402 0.396 1.000 
Mean   0.396 0.405 
 s.d.   0.113 0.098 
 * p < 0.00167; HWE = Hardy Weinberg Equilibrium 
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Table 4.1 (E) Allele frequencies and heterozygosity estimates for the the 30 
Indels for the Qiagen Investigator Kit in the Zulu population. 
 Zulu 
(N=103 ) 
  
Locus 
Deletion Allele  
Frequency 
Observed 
Heterozygosity 
(He) 
 Expected 
Heterozygosity 
(Ho) 
P-Value 
(HWE) 
HLD77 0.675 0.456 0.441 0.824 
HLD45 0.709 0.427 0.415 0.816 
HLD131 0.243 0.427 0.369 0.175 
HLD70 0.083 0.165 0.152 1.000 
HLD6 0.728 0.466 0.398 0.088 
HLD111 0.709 0.427 0.415 0.815 
HLD58 0.874 0.233 0.222 1.000 
HLD56 0.505 0.544 0.502 0.436 
HLD118 0.621 0.466 0.473 1.000 
HLD92 0.597 0.476 0.484 1.000 
HLD93 0.456 0.544 0.499 0.427 
HLD99 0.311 0.350 0.430 0.067 
HLD88 0.248 0.398 0.374 0.602 
HLD101 0.102 0.204 0.184 0.593 
HLD67 0.301 0.369 0.423 0.241 
HLD83 0.374 0.417 0.470 0.293 
HLD114 0.107 0.214 0.192 0.599 
HLD48 0.306 0.398 0.427 0.494 
HLD124 0.859 0.223 0.243 0.414 
HLD122 0.684 0.456 0.434 0.652 
HLD125 0.850 0.223 0.257 0.235 
HLD64 0.170 0.301 0.283 0.731 
HLD81 0.437 0.427 0.494 0.226 
HLD136 0.301 0.466 0.423 0.353 
HLD133 0.646 0.437 0.460 0.669 
HLD97 0.563 0.155 0.551 0.000* 
HLD40 0.796 0.311 0.326 0.760 
HLD128 0.330 0.408 0.444 0.501 
HLD39 0.345 0.515 0.454 0.196 
HLD84 0.282 0.388 0.407 0.635 
Mean 
 
0.376 0.388 
 s.d.   0.113 0.106   
* p < 0.00167; HWE = Hardy Weinberg Equilibrium  
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Table 4.2 (A) Forensic parameters for the 30 Indels from the Qiagen Investigator Kit in the Afrikaner population 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Afrikaner 
PD MP PE TPI PIC 
HLD77 7q31.1 rs1611048 0.627 0.373 0.183 0.990 0.375 
HLD45 2q31.1 rs2307959 0.619 0.381 0.192 1.010 0.373 
HLD131 7q36.2 rs1611001 0.595 0.405 0.220 1.074 0.369 
HLD70 6q16.1 rs2307652 0.643 0.357 0.151 0.918 0.374 
HLD6 16q13 rs1610905 0.632 0.368 0.167 0.953 0.373 
HLD111 17p11.2 rs1305047 0.591 0.409 0.240 1.122 0.374 
HLD58 5q14.1 rs1610937 0.592 0.408 0.240 1.122 0.374 
HLD56 4q25 rs2308292 0.609 0.391 0.124 0.856 0.350 
HLD118 20p11.1 rs16438 0.625 0.375 0.167 0.953 0.369 
HLD92 11q22.2 rs17174476 0.622 0.378 0.192 1.010 0.375 
HLD93 12q22 rs2307570 0.605 0.395 0.220 1.074 0.375 
HLD99 14q23.1 rs2308163 0.606 0.394 0.220 1.074 0.375 
HLD88 9q22.32 rs8190570 0.630 0.370 0.175 0.971 0.374 
HLD101 15q26.1 rs2307433 0.598 0.402 0.230 1.098 0.374 
HLD67 5q33.2 rs1305056 0.594 0.406 0.175 0.971 0.355 
HLD83 8p22 rs2308072 0.580 0.420 0.261 1.174 0.375 
HLD114 17p13.3 rs2307581 0.594 0.406 0.175 0.971 0.355 
HLD48 2q11.2 rs28369942 0.640 0.360 0.137 0.886 0.369 
HLD124 22q12.3 rs6481 0.594 0.406 0.192 1.010 0.360 
HLD122 21q22.11 rs8178524 0.595 0.405 0.230 1.098 0.373 
HLD125 22q11.23 rs16388 0.631 0.369 0.175 0.971 0.375 
HLD64 5q12.3 rs1610935 0.612 0.388 0.159 0.935 0.360 
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Table continued 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Afrikaner 
PD MP PE TPI PIC 
HLD81 7q21.3 rs17879936 0.630 0.370 0.175 0.971 0.374 
HLD136 22q13.1 rs16363 0.631 0.369 0.175 0.971 0.375 
HLD133 3p22.1 rs2067235 0.554 0.446 0.284 1.232 0.369 
HLD97 13q12.3 rs17238892 0.656 0.344 0.118 0.842 0.373 
HLD40 1p32.3 rs2307956 0.586 0.414 0.250 1.148 0.375 
HLD128 1q31.3 rs2307924 0.631 0.369 0.175 0.971 0.375 
HLD39 1p22.1 rs17878444 0.616 0.384 0.175 0.971 0.367 
HLD84 8q24.12 rs3081400 0.633 0.367 0.159 0.935 0.371 
Mean    0.612 0.388 0.191 1.009 0.370 
PD, Power of Discrimination; MP, Match Probability; PE, Power of Exclusion; TPI, Typical Paternity Index; 
PIC, Polymorphic Information Content 
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Table 4.2 (B) Forensic parameters for the 30 Indels from the Qiagen Investigator Kit in the Mixed Ancestry population 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Mixed Ancestry 
PD MP PE TPI PIC 
HLD77 7q31.1 rs1611048 0.588 0.412 0.205 1.040 0.361 
HLD45 2q31.1 rs2307959 0.610 0.390 0.196 1.020 0.370 
HLD131 7q36.2 rs1611001 0.606 0.394 0.214 1.061 0.373 
HLD70 6q16.1 rs2307652 0.541 0.459 0.110 0.825 0.308 
HLD6 16q13 rs1610905 0.618 0.382 0.129 0.867 0.356 
HLD111 17p11.2 rs1305047 0.598 0.402 0.188 1.000 0.361 
HLD58 5q14.1 rs1610937 0.587 0.413 0.171 0.963 0.350 
HLD56 4q25 rs2308292 0.627 0.373 0.110 0.825 0.358 
HLD118 20p11.1 rs16438 0.597 0.403 0.223 1.083 0.372 
HLD92 11q22.2 rs17174476 0.627 0.373 0.156 0.929 0.367 
HLD93 12q22 rs2307570 0.635 0.365 0.135 0.881 0.367 
HLD99 14q23.1 rs2308163 0.589 0.411 0.105 0.813 0.335 
HLD88 9q22.32 rs8190570 0.609 0.391 0.163 0.945 0.360 
HLD101 15q26.1 rs2307433 0.588 0.412 0.129 0.867 0.339 
HLD67 5q33.2 rs1305056 0.612 0.388 0.116 0.839 0.350 
HLD83 8p22 rs2308072 0.609 0.391 0.163 0.945 0.360 
HLD114 17p13.3 rs2307581 0.609 0.391 0.179 0.981 0.365 
HLD48 2q11.2 rs28369942 0.613 0.387 0.179 0.981 0.367 
HLD124 22q12.3 rs6481 0.634 0.366 0.163 0.945 0.373 
HLD122 21q22.11 rs8178524 0.589 0.411 0.149 0.912 0.345 
HLD125 22q11.23 rs16388 0.616 0.384 0.188 1.000 0.370 
HLD64 5q12.3 rs1610935 0.500 0.500 0.084 0.765 0.278 
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Table continued 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Mixed Ancestry 
PD MP PE TPI PIC 
HLD81 7q21.3 rs17879936 0.631 0.369 0.105 0.813 0.359 
HLD136 22q13.1 rs16363 0.622 0.378 0.188 1.000 0.374 
HLD133 3p22.1 rs2067235 0.606 0.394 0.116 0.839 0.347 
HLD97 13q12.3 rs17238892 0.649 0.351 0.059 0.703 0.367 
HLD40 1p32.3 rs2307956 0.558 0.442 0.188 1.000 0.339 
HLD128 1q31.3 rs2307924 0.627 0.373 0.179 0.981 0.374 
HLD39 1p22.1 rs17878444 0.612 0.388 0.196 1.020 0.371 
HLD84 8q24.12 rs3081400 0.582 0.418 0.156 0.929 0.343 
Mean 
  
0.603 0.397 0.155 0.926 0.355 
PD, Power of Discrimination; MP, Match Probability; PE, Power of Exclusion; TPI, Typical Paternity Index; 
PIC, Polymorphic Information Content 
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Table 4.2 (C) Forensic parameters for the 30 Indels from the Qiagen Investigator Kit in the Asian-Indian population 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Asian Indian 
PD MP PE TPI PIC 
HLD77 7q31.1 rs1611048 0.509 0.491 0.093 0.785 0.285 
HLD45 2q31.1 rs2307959 0.583 0.417 0.155 0.927 0.344 
HLD131 7q36.2 rs1611001 0.617 0.383 0.179 0.981 0.369 
HLD70 6q16.1 rs2307652 0.560 0.440 0.109 0.823 0.319 
HLD6 16q13 rs1610905 0.601 0.399 0.224 1.085 0.374 
HLD111 17p11.2 rs1305047 0.569 0.431 0.148 0.911 0.334 
HLD58 5q14.1 rs1610937 0.559 0.441 0.188 1.000 0.340 
HLD56 4q25 rs2308292 0.494 0.506 0.078 0.750 0.274 
HLD118 20p11.1 rs16438 0.590 0.410 0.244 1.133 0.375 
HLD92 11q22.2 rs17174476 0.634 0.366 0.155 0.927 0.371 
HLD93 12q22 rs2307570 0.635 0.365 0.163 0.944 0.373 
HLD99 14q23.1 rs2308163 0.600 0.400 0.188 1.000 0.362 
HLD88 9q22.32 rs8190570 0.625 0.375 0.121 0.850 0.358 
HLD101 15q26.1 rs2307433 0.642 0.358 0.155 0.927 0.375 
HLD67 5q33.2 rs1305056 0.619 0.381 0.196 1.020 0.375 
HLD83 8p22 rs2308072 0.594 0.406 0.115 0.836 0.340 
HLD114 17p13.3 rs2307581 0.614 0.386 0.179 0.981 0.367 
HLD48 2q11.2 rs28369942 0.609 0.391 0.215 1.063 0.375 
HLD124 22q12.3 rs6481 0.597 0.403 0.205 1.041 0.366 
HLD122 21q22.11 rs8178524 0.590 0.410 0.155 0.927 0.347 
HLD125 22q11.23 rs16388 0.592 0.408 0.234 1.109 0.373 
HLD64 5q12.3 rs1610935 0.463 0.537 0.074 0.739 0.253 
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Table continued 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Asian Indian 
PD MP PE TPI PIC 
HLD81 7q21.3 rs17879936 0.613 0.387 0.148 0.911 0.358 
HLD136 22q13.1 rs16363 0.625 0.375 0.188 1.000 0.375 
HLD133 3p22.1 rs2067235 0.620 0.380 0.128 0.864 0.357 
HLD97 13q12.3 rs17238892 0.569 0.431 0.034 0.638 0.334 
HLD40 1p32.3 rs2307956 0.559 0.441 0.093 0.785 0.316 
HLD128 1q31.3 rs2307924 0.595 0.405 0.234 1.109 0.374 
HLD39 1p22.1 rs17878444 0.620 0.380 0.196 1.020 0.375 
HLD84 8q24.12 rs3081400 0.579 0.421 0.115 0.836 0.331 
Mean   0.589 0.411 0.157 0.931 0.349 
PD, Power of Discrimination; MP, Match Probability; PE, Power of Exclusion; TPI, Typical Paternity Index; 
PIC, Polymorphic Information Content 
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Table 4.2 (D) Forensic parameters for the 30 Indels from the Qiagen Investigator Kit in the Xhosa population 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Xhosa 
PD MP PE TPI PIC 
HLD77 7q31.1 rs1611048 0.557 0.443 0.104 0.810 0.316 
HLD45 2q31.1 rs2307959 0.590 0.410 0.188 1.000 0.357 
HLD131 7q36.2 rs1611001 0.580 0.420 0.098 0.797 0.329 
HLD70 6q16.1 rs2307652 0.251 0.749 0.017 0.586 0.127 
HLD6 16q13 rs1610905 0.589 0.411 0.128 0.864 0.340 
HLD111 17p11.2 rs1305047 0.619 0.381 0.163 0.944 0.365 
HLD58 5q14.1 rs1610937 0.385 0.615 0.043 0.662 0.203 
HLD56 4q25 rs2308292 0.641 0.359 0.128 0.864 0.368 
HLD118 20p11.1 rs16438 0.615 0.385 0.163 0.944 0.363 
HLD92 11q22.2 rs17174476 0.617 0.383 0.167 0.954 0.365 
HLD93 12q22 rs2307570 0.577 0.423 0.266 1.186 0.375 
HLD99 14q23.1 rs2308163 0.568 0.432 0.109 0.823 0.324 
HLD88 9q22.32 rs8190570 0.569 0.431 0.163 0.944 0.338 
HLD101 15q26.1 rs2307433 0.372 0.628 0.031 0.630 0.203 
HLD67 5q33.2 rs1305056 0.603 0.397 0.148 0.911 0.352 
HLD83 8p22 rs2308072 0.611 0.389 0.188 1.000 0.368 
HLD114 17p13.3 rs2307581 0.444 0.556 0.050 0.680 0.244 
HLD48 2q11.2 rs28369942 0.543 0.457 0.141 0.895 0.316 
HLD124 22q12.3 rs6481 0.493 0.507 0.088 0.773 0.274 
HLD122 21q22.11 rs8178524 0.607 0.393 0.155 0.927 0.357 
HLD125 22q11.23 rs16388 0.364 0.636 0.026 0.614 0.203 
HLD64 5q12.3 rs1610935 0.468 0.532 0.061 0.708 0.257 
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Table continued 
HLD 
Chromosomal  
Location 
GenBank SNP 
ID 
Xhosa 
PD MP PE TPI PIC 
HLD81 7q21.3 rs17879936 0.632 0.368 0.171 0.962 0.374 
HLD136 22q13.1 rs16363 0.551 0.449 0.134 0.879 0.319 
HLD133 3p22.1 rs2067235 0.612 0.388 0.155 0.927 0.360 
HLD97 13q12.3 rs17238892 0.606 0.394 0.054 0.689 0.346 
HLD40 1p32.3 rs2307956 0.536 0.464 0.088 0.773 0.302 
HLD128 1q31.3 rs2307924 0.540 0.460 0.289 1.244 0.364 
HLD39 1p22.1 rs17878444 0.613 0.387 0.148 0.911 0.358 
HLD84 8q24.12 rs3081400 0.553 0.447 0.115 0.836 0.316 
Mean 
  
0.544 0.456 0.126 0.858 0.316 
PD, Power of Discrimination; MP, Match Probability; PE, Power of Exclusion; TPI, Typical Paternity Index; 
PIC, Polymorphic Information Content 
 
  
 
 
 
 
 96 
 
Table 4.2 (E) Forensic parameters for the 30 Indels from the Qiagen Investigator Kit in the Zulu population 
HLD 
Chromosomal  
Location 
GenBank 
SNP ID 
Zulu 
PD MP PE TPI PIC 
HLD77 7q31.1 rs1611048 0.583 0.417 0.152 0.920 0.343 
HLD45 2q31.1 rs2307959 0.566 0.434 0.131 0.873 0.328 
HLD131 7q36.2 rs1611001 0.521 0.479 0.131 0.873 0.300 
HLD70 6q16.1 rs2307652 0.276 0.724 0.021 0.599 0.140 
HLD6 16q13 rs1610905 0.536 0.464 0.159 0.936 0.318 
HLD111 17p11.2 rs1305047 0.566 0.434 0.131 0.873 0.328 
HLD58 5q14.1 rs1610937 0.372 0.628 0.039 0.652 0.196 
HLD56 4q25 rs2308292 0.600 0.400 0.229 1.096 0.375 
HLD118 20p11.1 rs16438 0.611 0.389 0.159 0.936 0.360 
HLD92 11q22.2 rs17174476 0.617 0.383 0.167 0.954 0.365 
HLD93 12q22 rs2307570 0.596 0.404 0.229 1.096 0.373 
HLD99 14q23.1 rs2308163 0.595 0.405 0.086 0.769 0.337 
HLD88 9q22.32 rs8190570 0.533 0.467 0.113 0.831 0.303 
HLD101 15q26.1 rs2307433 0.325 0.675 0.031 0.628 0.166 
HLD67 5q33.2 rs1305056 0.586 0.414 0.096 0.792 0.332 
HLD83 8p22 rs2308072 0.624 0.376 0.125 0.858 0.359 
HLD114 17p13.3 rs2307581 0.336 0.664 0.034 0.636 0.173 
HLD48 2q11.2 rs28369942 0.585 0.415 0.113 0.831 0.334 
HLD124 22q12.3 rs6481 0.390 0.610 0.036 0.644 0.213 
HLD122 21q22.11 rs8178524 0.576 0.424 0.152 0.920 0.339 
HLD125 22q11.23 rs16388 0.404 0.596 0.036 0.644 0.223 
HLD64 5q12.3 rs1610935 0.447 0.553 0.064 0.715 0.242 
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Table continued 
HLD 
Chromosomal  
Location 
GenBank 
SNP ID 
Zulu 
PD MP PE TPI PIC 
HLD81 7q21.3 rs17879936 0.645 0.355 0.131 0.873 0.371 
HLD136 22q13.1 rs16363 0.561 0.439 0.159 0.936 0.332 
HLD133 3p22.1 rs2067235 0.608 0.392 0.138 0.888 0.353 
HLD97 13q12.3 rs17238892 0.632 0.368 0.046 0.669 0.362 
HLD40 1p32.3 rs2307956 0.569 0.431 0.201 1.030 0.350 
HLD128 1q31.3 rs2307924 0.601 0.399 0.119 0.844 0.344 
HLD39 1p22.1 rs17878444 0.569 0.431 0.201 1.030 0.350 
HLD84 8q24.12 rs3081400 0.567 0.433 0.107 0.817 0.323 
Mean 
  
0.533 0.467 0.118 0.839 0.308 
PD, Power of Discrimination; MP, Match Probability; PE, Power of Exclusion; TPI, Typical Paternity Index; 
PIC, Polymorphic Information Content 
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Table 4.3 Combined indices for the 30 Indels from the Qiagen Investigator Kit in five South African populations 
Population 
Group 
CDP CMP CPE 
Afrikaner 0.9999999999996 4.25 X 10-13 0.9983 
Mixed Ancestry 0.9999999999992 8.50 X 10-13 0.9938 
Indian Asian 0.999999999998 2.23 X 10-12 0.9944 
Xhosa 0.99999999996 3.55 X10-11 0.9838 
Zulu 0.99999999994 6.42 X 10-11 0.9783 
CDP, Combined Power of Discrimination; CMP, Combined Match Probability; CPE, Combined Power of Exclusion 
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4.3.2 Population Comparisons 
4.3.2.1 Factorial Correspondence Analysis (FCA) 
Figure 4.1 represents a graph of the individuals belonging to the five South African 
populations. The graph illustrates the relationship between the individuals from the five 
populations. Individuals from each population can be seen clustered together. 
Individuals from the Xhosa and Zulu populations are closely clustered together, an 
indication of genetic similarities between the two populations. The Mixed Ancestry 
individuals are dispersed throughout the graph, indicating genetic similaries shared with 
the other populations whereas the Afrikaner and Indian-Asian individuals are more 
distinctive indicating decreased genetic relationship with these populations. Figure 4.2 
shows the FCA relationship between the five populations and their genetic relatedness. 
The genetic distance between the populations is shown, with populations sharing 
genetic similarities being located close to each other and populations located far apart 
not sharing a high degree of genetic similarity. The centralised positioning of the Mixed 
Ancestry population indicates this population‘s shared genetic relationship with all four 
populations. 
 
4.3.2.2. FST-Analysis 
Table 4.4 shows the pairwise genetic distance as calculated between the five 
populations by the program Arlequin (Excoffier et al, 2005) with the probability values 
of the pairwise genetic distances shown. The genetic distance estimates results show the 
Zulu population being closer to the Xhosa population ( = 0.00125, -0.01235 < p < 
0.16504) and being the furthest from the Afrikaner ( = 0.11886, p < 0.05) and Indian-
Asian populations ( = 0.10909, p < 0.05). There is indication of genetic similarity 
between the Mixed Ancestry population and each of the four populations i.e. Afrikaner 
population ( = 0.03020, p < 0.00000), Indian-Asian population ( = 0.02149,  
p < 0.00000), Xhosa population ( = 0.03568, p < 0.00000) and Zulu population  
( = 0.04800, p < 0.00000). 
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Figure 4.1 Factorial Correspondence Analysis (FCA) of five South African populations’ individuals. A graphical illustration of 
the individuals belonging to the five South African populations as constructed using Genetix v.4.05.2. (Belkhir et al, 2002). 
  Afrikaner Individual 
 Indian-Asian Individuals 
 Mixed Ancestry Individuals 
Xhosa Individuals 
 
Zulu Individuals 
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Figure 4.2 Factorial Correspondence Analysis (FCA) of five South African populations. A graphical illustration of the five 
South African populations as constructed using Genetix v.4.05.2. (Belkhir et al, 2002). 
Indian-Asian 
Zulu Xhosa 
Mixed Ancestry 
Afrikaner 
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Table 4.4 Population pairwise genetic distances among the five populations (FST values below diagonal) using Arlequin (Excoffier et al, 
2005) with corresponding p-values (above diagonal) (p > 0.05) 
Populations Afrikaner Indian-Asian Coloured Xhosa Zulu 
Afrikaner - 0.00000+-0.0000* 0.00000+-0.0000* 0.00000+-0.0000* 0.00000+-0.0000* 
Indian-Asian 0.03919 - 0.00000+-0.0000* 0.00000+-0.0000* 0.00000+-0.0000* 
Coloured 0.03020 0.02149 - 0.00000+-0.0000* 0.00000+-0.0000* 
Xhosa 0.09887 0.08573 0.03568 - 0.16504+-0.0123 
Zulu 0.11886 0.10909 0.04800 0.00125 - 
*p < 0.05 
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4.3.2.3 Phylogenetic tree construction 
Table 4.5 shows the genetic distance as calculated between the five populations 
by the program TreeFit. The genetic distance estimates results are similar to the 
results shown in section 4.3.2.2 with the Zulu population being closer to the 
Xhosa population ( = 0.0012) and being the furthest from the Afrikaner  
( = 0.119) and Indian-Asian populations ( = 0.0992). 
The degree of fit degree of fit between observed data and phylogenetic tree 
construction is summarized in Table 4.6 with an R
2
-value of 0.998. The 
phylogenetic tree constructed using the NJ method is shown in Figure 4.3. The 
tree illustrates the same interpopulation relationships between the five populations 
as observed with the FCA method. The Xhosa and Zulu populations are clustered 
closely together on the tree, an indication of close genetic similarities shared. 
 
Table 4.5 Population comparison of the five populations using genetic distance 
(FST) (Weir and Cockerham, 1984) by Treefit. 
Populations Afrikaner 
Indian-
Asian 
Coloured Xhosa Zulu 
Afrikaner 0.0000 
 
   
Indian-
Asian 
0.0392 0.0000    
Coloured 0.0302 0.0214 0.0000 
 
 
Xhosa 0.0992 0.0857 0.0356 0.0000  
Zulu 0.119 0.1089 0.0477 0.0012 0.0000 
 
4.4 Summary 
A higher number of heterozygotes are indicative of high genetic diversity within a 
population whereas a low number of heterozygotes would indicate low genetic 
diversity. Genetic diversity was high especially in the Afrikaner population. The 
kit is shown to be highly polymorphic. For all forensic indices the Afrikaner 
population had the highest values. Surprisingly, compared to the Afrikaner 
population, lower estimates in genetic diversity and forensic indices were  
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Table 4.6 Summary of observed genetic distances (Weir and Cockerham‘s 1984) 
versus data fitted in the phylogenetic tree (NJ method) as calculated using Treefit. 
  
Observed D Fitted D 
Afrikaner Indian-Asian  0.0392 0.0392 
Afrikaner Coloured 0.0302 0.0309 
Afrikaner Xhosa 0.0992 0.0991 
Afrikaner Zulu 0.119 0.1176 
Indian-Asian Coloured 0.0214 0.0207 
Indian-Asian Xhosa 0.0857 0.0889 
Indian-Asian Zulu 0.1089 0.1073 
Coloured Xhosa 0.0356 0.0325 
Coloured Zulu 0.0477 0.0509 
Xhosa Zulu 0.0012 0.0012 
R
2
 = 0.998       
D = Degree of Fit 
 
 
Figure 4.3 Phylogenetic tree construction of the five South African 
populations. A phylogenetic tree constructed using Treefit (Kalinowski, 2009) 
and visualised using TreeView (Paper, 2006). The Neighbour-Joining method was 
used and genetic distances estimated using Weir and Cockerham (1984).  
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observed in the other four populations. For all forensic parameters, the highest 
values were estimated in the Afrikaner populations and the lowest values were 
estimated in the Black populations. This was also observed in other populations 
using the Investigator kit. In Finnish and Danish populations combined match 
probability values of 3.54 X 10
-13
 (Neuvonen et al, 2012) and 3.3 X 10
-13
 (Friis et 
al, 2012) were estimated, respectively. While in the African American population 
a combined match probability value of 1.43×10
-11
 (LaRue et al, 2012) was 
estimated. The Mixed Ancestry population is historically and genetically linked to 
all the other populations. The statistical analysis performed shows evidence of 
this. It is reflected in the genetic distance measures which show genetic 
differentiation between the Mixed Ancestry and each of the remaining four 
populations. FCA and phylogenetic tree construction illustrates the genetic 
relationship between the Mixed Ancestry population with the remaining four 
populations, with the Mixed Ancestry population being located centrally on both 
the phylogenetic tree as well as the scatter plots constructed using FCA. 
Population comparison also confirmed close genetic links between the Xhosa and 
Zulu populations. The Mixed Ancestry and Indian-Asian populations also share 
genetic similarities with the Xhosa and Zulu populations and might also 
genetically be predisposed to the mutation causing the HLD97 null allele. 
The data strongly indicates the presence of a null allele at locus HLD97 in the 
Mixed Ancestry and Indian-Asian populations i.e. high null allele frequencies and 
Hardy-Weinberg disequilibrium being detected by statistical analysis. Null alleles 
negatively affect heterozygosity levels and therefore genetic diversity. The issue 
of null alleles should be addressed if the presence of null alleles is suspected. 
The Afrikaner population shared the least genetic similarity with the four 
populations. The results for population comparison indicate the presence of 
population substructure resulting in individuals from the same population sharing 
more genetic similarities. The implication of subpopulations in forensics is that 
this can lead to errors when it comes to estimation of population frequencies and 
therefore correction for population substructure using a tetha value should be 
considered and implemented (Balding and Nichols, 1994).  
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Chapter 5 
Conclusions and recommendations 
 
The Investigator DIPplex kit was assessed based on its application in forensics, 
specifically on South African populations as well as looking at qualities which 
will aid in improving turnaround time, streamlining efficiency and delivering of 
quality results. 
On its performance in the laboratory the Investigator DIPplex kit performed well. 
As the kit is already optimised, it makes it easy to use and less labour intensive. 
The low amount of input DNA required makes it ideal for application in forensic 
work. In terms of laboratory application, the Investigator DIPplex kit basically has 
no drawbacks. The kit has been shown to be robust and the results reproducible, 
all qualities that are ideal for streamlining laboratory work and increasing 
turnaround time. The marker panel consists of thirty indels. PCR amplification 
and data analysis with the Investigator kit is fast with high output of good quality 
data in a short amount of time. The kit can be used with older or newer 
genotyping platforms i.e. the 3100 to 3500xl sequencing instruments. This allows 
for delivering of results using simple PCR amplification to capillary 
electrophoresis processing. 
Despite these advantages, indels are di-allelic markers. This one characteristic 
makes the kit more ideal as a supplementary forensic kit than a stand-alone kit as 
the amount of markers are not sufficient compared to STRs, with the statistical 
values of the combined match probability being lower than that of the current 
forensic kit applied by SAPS. SAPS forensics laboratories are in the process of 
migrating to chemistries which incorporates more loci, as much as fifteen STR 
loci. However, currently, SAPS forensics laboratories are using the AmpFLSTR 
Profiler Plus™ PCR Amplification kit (Life Technologies). The kit amplifies nine 
STR loci namely D3S1358, D5S818, D7S820, D8S1179, D13S317, D18S51, 
D21S11, FGA, and vWA as well as a tenth gender determining locus, 
Amelogenin. SAPS forensic laboratories deal with cases of missing persons and 
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victim identification as well as mass disasters. SAPS forensic laboratories can 
benefit from making use of this kit to aid in DNA profiling of degraded DNA as 
STR analysis is not as successful in DNA typing badly degraded DNA, as in the 
case of mass disasters. 
This is the first time Investigator DIPplex kit has been applied on South African 
populations. The data presented has demonstrated the presence of a null allele in 
elevated frequency in the Xhosa and Zulu populations at locus HLD97. Null 
alleles have a negative effect on population genetic diversity estimation by 
decreasing heterozygosity, as well as in kinship analysis. I recommend that the 
manufacturers of the kit look at the HLD97 locus and possibly redesigning the 
primers so that the primer binding sites are located away from the problem area. 
Another option the manufacturers should consider is designing degenerate 
primers, taking into consideration the mutation site and these primers can be used 
from the onset, in addition to the original primer set to prevent the lack of PCR 
amplification at the HLD97 locus. This will accommodate individuals that possess 
the polymorphism site and result in successful amplification of all individuals in 
the South African population. 
My recommendation to the users is to exclude the locus containing the null allele 
from kinship analysis or repeating the PCR using a lower Tm which will result in 
lower primer binding stringency and amplification of the HLD97 null allele. 
The data presented in this study has further indicated the presence of population 
substructure within the South African population. Considering the kit is designed 
for application in forensics, this will have an effect on allele frequencies used to 
calculate match probabilities.  
Due to the fact that populations are not homogeneous and allele frequencies vary 
across populations, there is strong bias based on which allele frequencies are used. 
By using allele frequencies that are not population specific it can negatively affect 
the calculated match probabilities, and lead to stronger biased evidence against the 
suspect. Or in the case of missing persons, it could lead to weak statistical 
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evidence resulting in unsuccessful victim identification. Therefore allele 
frequencies need to be sampled from specific populations. 
I suggest applying allele frequencies obtained from the specific subpopulation to 
which a person of interest belong to, to be representative and give accurate 
estimations of match probabilities which would work in the defence‘s favour, 
especially in kinship analysis. I recommend applying a theta value to correct for 
population substructure which is present within the South African populations. In 
this study theta values in the range of 0.00116 and 0.11903 were estimated using 
FST analysis. 
Furthermore, in the event of person of interest‘s population of origin being 
unknown, a theta value should be used for calculating match probabilities, by 
applying allele frequencies from population groups which would best be 
representative of that individual‘s population. In cases of victim identification I 
recommend using the population group that possible relatives of the missing 
person belong to and making use of allele frequencies sampled from the 
geographical area that the missing person is from, for kinship analysis. 
However, caution should be applied when choosing allele frequencies for FST 
analysis i.e. using overall allele frequencies. As allele frequencies between 
different geographical regions vary, the choice of allele frequencies should be as 
representative as possible as this will directly affect FST analysis and the 
calculated theta value (Toscanini et al, 2012). Currently, SAPS Forensic Science 
Laboratories apply the equations as recommended by the National Research 
Council (1996) for correction of population substructure by using a theta value of 
0.01 for urban populations and 0.03 for rural populations and make use of allele 
frequencies from the four main population groups in South Africa i.e. Black, 
Coloured, Indian and White. 
Overall, the kit will perform well and will serve a better purpose as a 
supplementary kit, specifically where other forensic markers are unsuccessful like 
genotyping of degraded DNA. 
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 121 
 
Appendix 
1 DNA Extraction, Quantification and Working Stock Solutions 
1.1 Lahiri and Nurnberger (1991) DNA Extraction Protocol 
1.1.1 Reagents (To be autoclaved immediately after preparation) 
 
TKM I (100 ml) 
1M Tris, pH 8.0 (Merck Laboratory Supplies) 1 ml 
100 mM KCl (Merck Laboratory Supplies) 10 ml 
200 mM MgCl2 (Merck Laboratory Supplies) 5 ml 
100 mM EDTA (Merck Laboratory Supplies) 2 ml 
Distilled H2O 82 ml 
 
TKM I + Nonidet P40 (100 ml) 
1 M Tris, pH 8.0 (Merck Laboratory Supplies) 1 ml 
100 mM KCl (Merck Laboratory Supplies) 10 ml 
200 mM MgCl2 (Merck Laboratory Supplies) 5 ml 
100 mM EDTA (Merck Laboratory Supplies) 2 ml 
Distilled H2O 82 ml 
Nonidet P40 (Sigma) 2.25 ml 
 
TKM II (100 ml) 
1 M Tris, pH 8.0 (Merck Laboratory Supplies) 1 ml 
 
 
 
 
 122 
 
100 mM KCl (Merck Laboratory Supplies) 10 ml 
200 mM MgCl2 (Merck Laboratory Supplies) 5 ml 
100 mM EDTA (Merck Laboratory Supplies) 2 ml 
2 M NaCl (Merck Laboratory Supplies) 20 ml 
Distilled H2O 62 ml 
 
10 % w/v SDS (100 ml) 
SDS (Merck Laboratory Supplies) 10 g 
Distilled H2O 100 ml 
 
2 M NaCl (100 ml) 
NaCl (Merck Laboratory Supplies) 11.67 g 
Distilled H2O 100 ml 
 
1.1.2 DNA Extraction steps 
1. 0.5 ml of carefully mixed whole blood was transferred to a clean, dry, 
APPROPRIATELY LABELLED 1.5ml microfuge tube. 
2. 0.5 ml of sterile [TKM I + Nonidet P-40] was added to the 0.5 ml blood and the 
contents of the tube mixed gently by inversion. 
3. The tube was then placed in a bench-top centrifuge (Eppendorf, 5415 D) and 
the mixture centrifuged at 5000 rpm for 10 minutes to pellet the nuclei. 
4. The supernatant was then carefully removed, paying attention to not disturb the 
pellet. 
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5. The pellet was then washed by adding 0.5 ml sterile TKM I to it. 
6. The tube was centrifuged for 10 minutes at 5000 rpm. 
7. The supernatant was removed again. This time, extra care was taken to remove 
as much of it as possible, without disturbing the pellet. 
8. 70 µL of sterile TKM II was added to the pellets and tube vortexed (Stuart 
Scientific, vortex mixer SA3) until the pellet was completely re-suspended in the 
liquid. 
9. 4.37 µL of sterile 10 % w/v SDS was added to this mix and the tube vortexed 
briefly. 
10. The tube was then incubated in a water-bath (Memmert) at 55 
o
C for 10 
minutes. 
11. After incubation, 264 ul of sterile 2 M NaCl was added and the tube vortexed 
briefly. 
12. The tube was then centrifuged at 13000 rpm for five minutes to pellet extra-
cellular components. 
13. After centrifugation, the supernatant was transferred to a clean, dry and 
CORRECTLY LABELLED, 1.5ml microfuge tube. 
14. To this supernatant, 677 µL of absolute ethanol (room temperature) was added 
and the contents of the tube mixed gently by inverting it a few times. At this point 
the DNA became visible. 
15. The tube was then centrifuged at 13000 rpm for five minutes to pellet the 
DNA. (The DNA did not always end up at the bottom of the tube, but sometimes 
got stuck on the side of the tube). 
16. The supernatant was then removed and the tube centrifuged again at 13000 
rpm. 
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17. The supernatant was removed after centrifugation and 250 µL of ice-cold  
70 % ethanol added to wash the DNA. 
18. The tube was then centrifuged at 13000 rpm for five minutes and the 
supernatant removed. 
19. Step 17 and 18 were repeated. 
21. The DNA was dried at room temperature, re-suspended in 100 µL of sterile 
distilled water and the DNA allowed to go into solution at room temperature 
overnight. 
All the blood waste from the DNA extraction process were decanted into 
appropriate containers, sealed properly, clearly labelled as blood waste and 
discarded in an appropriate manner by Waste Tech, an accredited waste removal 
company. 
 
2. DNA Extraction, Quantification and Working Stock Solutions from buccal 
swabs 
2.1 Proteinase K and Salting Lysis method (Medrano, 1990). 
2.1.1. Preparation of the lysis buffer: 
1. Proteinase K stock is 20mg/ml and stored at -20 
o
C. 
2. Add 400 mM NaCl [2 M], 10 mM Tris-ClH pH8 [1 M] and 2 mM EDTA  
[0.5 M] in 80 % of their final volume, in distilled water. 
3. Add 1 % SDS [MW = 288.4]. Leave in the oven at 60 
o
C until fully dissolved. 
Transfer to a volumetric flask and add the required volume of SABAX water to 
get 100 % desired volume. 
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2.1.2. DNA sample collection using buccal swabs 
1. Cut off the surface of the swab by using a clean scalpel or surgery blade, 
working on a clean surface. 
2. Prepare 1.5 ml or 2 ml Eppendorf tubes and add a volume of lysis buffer and 
proteinase K. The final working solution of proteinase K should be 0.1mg/ml.  
3. Add pieces of the cut swab to the Eppendorf tubes and vortex for 30 seconds. 
Incubate overnight at 56 
o
C. 
4. Transfer the total volume to a clean Eppendorf tube.  
5. To recover the lysis solution and biological material trapped in the swab pieces 
the following steps can be taken: perforate the end of a 0.5 ml tube with a needle. 
Place the perforated tube inside a 1.5 ml Eppendorf tube. Spin for 1 minute in a 
microcentrifuge and add the collected volume to the previously collected lysis 
material. 
6. Add 1/3 volume of 6 M NaCl and precipitate by shaking the tube(s) vigorously 
for 15 seconds.  
7. Centrifuge the tube(s) for 15 minutes at 5000rpm and transfer the supernatant 
containing the DNA to another tube. 
8. Add an equal volume of cold isopropanol to the tube(s). Leave to stand 
overnight at -2
 o
C or at -80 
o
C for 30 minutes.  
9. Centrifuge at 14000rpm for 30 minutes to pellet the DNA. Remove salts by 
washing the pellet with 100uL of 70 % ethanol. 
10. Repeat the centrifugation at 14000rpm for 8 minutes to 30 minutes. Dry the 
pellet briefly in a SpeedyVac or at 65
 o
C. Take care to keep the drying process 
short as over drying will prevent subsequent dissolving in 50uL SABAX water. 
Store at -20
 o
C. 
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3. Positive control sample for PCR amplification 
Control DNA XY5 (Qiagen) [2.0 ng/ul] 
 
3.1 Dilution of positive control 
A working stock solution was prepared by diluting the positive control from 2 ng 
to 0.35 ng by adding 3.5 µL positive control to 16.5 µL SABAX water. The stock 
solution mixed by pipette and stored at -20 
o
C. 
 
Preparation of dNTPs mix 
-Deoxynuceotide Triphosphate Set PCR grade (Roche Diagnostics) 
 
Mix each tube of dNTP well by vortexing. Take 10 µL of each dNTP and add to 
98 µL SABAX water. Mix well by vortexing and spin down. 
 
4. Gel electrophoresis and working stock solutions 
4.1 Reagents 
10X TBE Buffer 1 L 
Tris-HCl 108 g 
Boric acid 55 g 
0.5 M EDTA 40ml 
dH2O 1 L 
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4.2.1 Preparation of a 1 % agrose gel 
Add 1.0 g SeaKem® LE agarose (WhiteSci) to 50 ml 1 X TBE buffer. Mix the 
solution and heat in a microwave, mixing the solution until the agarose gel is 
dissolved. Take care not to stir too vigorously as to have bubbles forming. Taking 
care for bubble formation, pour the agarose mixture in a 100 ml loading tray and 
leave to set. 
 
3. DNA sequencing 
3.1 Genbank sequence of HLD97 
>gi|224589804:31328000-31328884 Homo sapiens chromosome 13, GRCh37.p10 
Primary Assembly 
GGAGCAGAATCATTCAGATGGTATAACATAAGGAAAAACTTTGCCCAAGGCAAATCGTGATTGT
GACAGCTTTGTGATTTTTAGAGAATAGCATGGGCCAGGCACAGTGGCTCATGCCTGTAATCCCA
GCACTTTGGGAGGCCGAGGCAGGCAGGTCACTTGAGGTTGGGAGTTCGACAACAGCCTGACCA
ACATGGAGAAACCCTGTCTCTACTAAAAATACAAAATTAGCTGGGCGTGGTGGTGCATGCCTGT
AATGCCAGCTACTCGGGAGGCTGAGGCAGGAGAATCACTTAAACCTGGGAGGCGGAGGTTGCG
GTGAACCAAGATAGCACCATTGCACTCCAGCCTGGGCAACAAGAGTGAAACTCCGTCTCAAAA
AGAGTTCACAGTTTCTCTTTTGCTTTGATTTTCTTATCTGCCGGATAACAATAGTATTTTGGAAGG
CAGGAGGAATTGTGGAAAGAAATGGGTTTTGGGGAGTGGCTGATTGGAGGCAAATCCAAGGAC
ACTCATTGCTGGTGTGTGACTCCAGGCAGTTACTCAGCTTTTCCAAGCCTCAGTTTCCTTATTGTA
AAACAGGACCATGGTCTAGCTAGTAGCATTCCTATGGTGAGTGAAATAATATGTATAAAGCTCC
TGACACAGTGCTTGGCATATATCAGATTGAGCCATGTAAAACTGCCAATATCTGGCTATTTATGA
CCTACAAAAATAGCATTTCATATGATTCCACCTAACATCTGAAGCGCAATAAATGTTATTATTGA
TAATGCAGGTGGTGGTGATAAAGTTTTGAAATCAGAAAGACCTGGCTTCAAATTCCACGCCTTC
ACTGGCCTGACTTATTTTCATTCATTTGACAAATATTATTTTGAACACCCC 
 
 
 
 
